<?xml version="1.0" encoding="UTF-8"?>
<svg height="778.0" width="557.949" xmlns="http://www.w3.org/2000/svg">
 <g id="page" xmlns:svgx="http://www.xml-cml.org/schema/svgx">
  <path style="fill:none;stroke:rgb(0,0,0);stroke-width:1.0;" d="M62.360 53.720 L545.670 53.720 "/>
  <g begin="text">
   <text y="49.34" x="62.362,66.842,71.322,74.862,77.672,82.052,85.182,87.962,92.542,96.922,100.462,104.002,105.882,110.362,115.052,117.832,123.042,125.022,127.802,133.012,138.222,141.002,143.922,148.502,153.712,156.632" svgx:width="0.45,0.45,0.35,0.28,0.44,0.31,0.28,0.46,0.44,0.35,0.35,0.19,0.45,0.47,0.28,0.52,0.2,0.28,0.52,0.52,0.28,0.29,0.46,0.52,0.29,0.28" style="fill:rgb(0,0,0);font-family:GillSansStd-Italic;font-size:10.0px;stroke:none;">Poster session 2, 20 (s1) </text>
   <text y="49.34" x="530.672,535.672,540.672" svgx:width="0.5,0.5,0.5" style="fill:rgb(0,0,0);font-family:GillSansStd;font-size:10.0px;stroke:none;">479</text>
  </g>
  <g begin="text">
   <text y="768.0" x="355.802,363.932,368.622,370.502,373.312,375.192,380.092,381.972,386.352,389.132,393.712,397.562,399.442,403.822,406.952,411.432,414.972,416.852,420.392,423.172,425.572,430.052,434.742,437.872,442.562,447.252" svgx:width="0.81,0.47,0.19,0.28,0.19,0.49,0.19,0.44,0.28,0.46,0.38,0.19,0.44,0.31,0.45,0.35,0.19,0.35,0.28,0.24,0.45,0.47,0.31,0.47,0.47,0.19" style="fill:rgb(0,0,0);font-family:GillSansStd-Italic;font-size:10.0px;stroke:none;">Multiple Sclerosis Journal</text>
   <text y="768.0" x="449.132,451.912,456.912,461.912,466.912,471.912,474.102,476.882,481.882,486.882,489.072,491.852,495.082,499.662,504.662,507.892,510.672,515.672,520.672,525.672,530.672,535.672,540.672" svgx:width="0.28,0.5,0.5,0.5,0.5,0.22,0.28,0.5,0.5,0.22,0.28,0.32,0.46,0.5,0.32,0.28,0.5,0.5,0.5,0.5,0.5,0.5,0.5" style="fill:rgb(0,0,0);font-family:GillSansStd;font-size:10.0px;stroke:none;"> 2014; 20: (S1) 285–496</text>
  </g>
  <g begin="text">
   <text y="768.0" x="61.186,68.896,72.746,74.936,77.126,80.976,85.246,89.516,94.306,99.306,104.306,109.206,111.396,115.776,121.296" svgx:width="0.77,0.38,0.22,0.22,0.38,0.43,0.43,0.48,0.5,0.5,0.5,0.22,0.44,0.55,0.77" style="fill:rgb(0,0,0);font-family:GillSansStd;font-size:10.0px;stroke:none;">msj.sagepub.com</text>
  </g>
  <path style="fill:none;stroke:rgb(0,0,0);stroke-width:0.25;" d="M62.360 506.300 L144.100 506.300 "/>
  <g begin="text">
   <text y="77.103" x="62.362,66.862,70.858,77.86,81.856,86.356,90.856,93.358,97.858,102.358,104.707,108.703,113.203,120.205,124.705,128.701,131.698,135.199,139.699,146.701,150.697,153.046,157.546,162.046,164.548,167.05,169.552,172.549,176.545,179.047,181.549,186.049,190.549,192.799,194.986,200.485,204.985,208.981,211.33,215.326,219.826,222.823,225.82,229.816,234.316,236.818,239.167,242.164,246.664,249.661,256.663,261.163,263.665,267.661,270.163,272.665,277.165,281.665,284.014,290.512,294.508,298.009" svgx:width="0.5,0.44,0.78,0.44,0.5,0.5,0.28,0.5,0.5,0.25,0.44,0.5,0.78,0.5,0.44,0.33,0.39,0.5,0.78,0.44,0.25,0.5,0.5,0.28,0.28,0.28,0.33,0.44,0.28,0.28,0.5,0.5,0.25,0.25,0.61,0.5,0.44,0.25,0.44,0.5,0.33,0.33,0.44,0.5,0.28,0.25,0.33,0.5,0.33,0.78,0.5,0.28,0.44,0.28,0.28,0.5,0.5,0.25,0.72,0.44,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">demanding cumbersome uptitration. The current formulation was </text>
   <text y="88.101" x="62.362,66.862,70.858,75.358,79.354,81.856,86.356,90.856,94.852,99.352,101.602,102.628,105.13,109.63,111.88,112.906,117.406,121.906,125.902,128.899,132.895,137.395,144.397,148.393,150.643,151.669,154.171,158.671,161.173,164.674,166.924,167.95,171.946,176.446,180.946,183.196,184.222,186.724,193.726,198.226,201.223,205.723,210.223,214.219,216.469,217.495,221.491,223.993,226.495,230.995,233.497,237.493,241.489,243.991,246.241,247.267,251.263,255.763,260.263,262.765,265.267,269.263,273.259,275.761,278.263,282.763,287.263,289.513,290.539,295.039,298.036" svgx:width="0.5,0.44,0.5,0.44,0.28,0.5,0.5,0.44,0.5,0.25,0.55,0.28,0.5,0.25,0.55,0.5,0.5,0.44,0.33,0.44,0.5,0.78,0.44,0.25,0.55,0.28,0.5,0.28,0.39,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.28,0.78,0.5,0.33,0.5,0.5,0.44,0.25,0.55,0.44,0.28,0.28,0.5,0.28,0.44,0.44,0.28,0.25,0.55,0.44,0.5,0.5,0.28,0.28,0.44,0.44,0.28,0.28,0.5,0.5,0.25,0.55,0.5,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">developed to overcome this and improve clinical application of </text>
   <text y="99.099" x="62.362" svgx:width="0.64" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Δ</text>
   <text y="96.583" x="68.149" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">9</text>
   <text y="99.103" x="71.074,74.071,79.57,86.068,92.071,94.321,96.823,101.323,103.573,106.075,110.575,114.571,116.821,119.323,122.32,126.316,130.312,132.814,139.816,143.812,148.312,150.814,153.064,157.564,160.561,162.811,166.312,170.812,174.808,178.309,180.811,183.313,187.309,189.811,192.313,196.813,199.063,203.059,207.559,212.059,214.309,218.809,222.805,225.307,229.807,232.057,234.559,239.059,241.309,249.31,254.314" svgx:width="0.33,0.61,0.72,0.67,0.25,0.28,0.5,0.25,0.28,0.5,0.44,0.25,0.28,0.33,0.44,0.44,0.28,0.78,0.44,0.5,0.28,0.25,0.5,0.33,0.25,0.39,0.5,0.44,0.39,0.28,0.28,0.44,0.28,0.28,0.5,0.25,0.44,0.5,0.5,0.25,0.5,0.44,0.28,0.5,0.25,0.28,0.5,0.25,0.89,0.56,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">-THC in the treatment of spasticity and pain in MS.</text>
   <text y="110.101" x="62.362,69.364,74.368,77.365,81.361,85.357,88.354,90.856,95.356,99.352,102.853,105.85" svgx:width="0.78,0.56,0.33,0.44,0.44,0.33,0.28,0.5,0.44,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Objectives: </text>
   <text y="110.101" x="107.974,113.473,117.973,121.969,124.093,128.089,130.591,137.593,139.717,144.217,147.214,149.338,151.84,156.34,160.336,162.46,166.96,169.957,173.953,177.454,181.45,185.95,188.452,190.576,194.077,196.579,201.079,205.579,210.079,212.203,218.701,222.697,226.198,228.322,230.824,235.324,237.448,241.444,245.944,249.94,252.442,256.942,260.938,263.44,267.436,269.56,272.062,276.562,280.558,282.682,286.678,289.513,292.51,295.012" svgx:width="0.61,0.5,0.44,0.25,0.44,0.28,0.78,0.25,0.5,0.33,0.25,0.28,0.5,0.44,0.25,0.5,0.33,0.44,0.39,0.44,0.5,0.28,0.25,0.39,0.28,0.5,0.5,0.5,0.25,0.72,0.44,0.39,0.25,0.28,0.5,0.25,0.44,0.5,0.44,0.28,0.5,0.44,0.28,0.44,0.25,0.28,0.5,0.44,0.25,0.44,0.33,0.33,0.28,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">The aim of the present study was to evaluate the effi-</text>
   <text y="121.099" x="62.362,66.358,70.354,74.35,78.85,81.748,86.248,89.245,92.143,96.139,99.037,103.537,108.037,112.537,116.533,119.035,121.933,126.433,129.43,133.426,135.928,138.826,141.823,146.323,149.32,156.322,160.822,163.324,167.32,169.822,172.324,176.824,181.324,184.222,188.722,191.719,194.122" svgx:width="0.44,0.44,0.44,0.5,0.25,0.5,0.33,0.25,0.44,0.25,0.5,0.5,0.5,0.44,0.28,0.25,0.5,0.33,0.44,0.28,0.25,0.33,0.5,0.33,0.78,0.5,0.28,0.44,0.28,0.28,0.5,0.5,0.25,0.5,0.33,0.25,0.64" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">cacy of a novel oral formulation of Δ</text>
   <text y="118.583" x="199.908" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">9</text>
   <text y="121.103" x="202.833,205.83,211.329,217.827,223.83,226.728,229.725,235.224,241.227,246.231,250.731,255.231,259.731,266.229,269.226,272.124,274.626,279.126,282.024,284.526,287.523,291.519,295.515,298.017" svgx:width="0.33,0.61,0.72,0.67,0.25,0.33,0.61,0.67,0.56,0.5,0.5,0.5,0.72,0.33,0.25,0.28,0.5,0.25,0.28,0.33,0.44,0.44,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">-THC (ECP002A) to treat </text>
   <text y="132.101" x="62.361,65.862,70.362,74.358,77.859,80.361,82.863,86.859,89.361,91.863,95.778,98.028,100.278,101.088,105.588,109.584,112.086,116.586,118.836,119.646,123.642,128.142,132.642,134.892,135.702,138.204,145.206,149.706,152.703,157.203,161.703,165.699,167.949,168.759,171.756,176.256,180.756,184.752,187.254,189.756,194.256,198.756,202.752,205.254,207.504,208.314,212.814,217.314,219.816,223.812,228.312,235.314,239.31,241.56,242.37,249.372,253.368,257.364,260.865,265.365,268.362,272.358,275.859,278.109,278.919,281.421,285.921,288.171,288.981,293.481,297.981" svgx:width="0.39,0.5,0.44,0.39,0.28,0.28,0.44,0.28,0.28,0.5,0.25,0.25,0.55,0.5,0.44,0.28,0.5,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.28,0.78,0.5,0.33,0.5,0.5,0.44,0.25,0.55,0.33,0.5,0.5,0.44,0.28,0.28,0.5,0.5,0.44,0.28,0.25,0.55,0.5,0.5,0.28,0.44,0.5,0.78,0.44,0.25,0.55,0.78,0.44,0.44,0.39,0.5,0.33,0.44,0.39,0.25,0.55,0.28,0.5,0.25,0.55,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">spasticity, pain and improve functional outcome measures in 24 </text>
   <text y="143.099" x="62.361,66.861,70.857,73.359,75.861,79.857,84.357,86.859,90.36,92.61,99.108,101.61,104.112,108.612,110.862,115.362,118.359,120.861,127.863,131.859,134.856,139.356,141.606,146.106,149.103,151.353,154.854,158.85,162.846,167.346,171.846,176.346,180.342,183.339,187.839,190.089,194.589,197.586,202.086,206.586,209.583,213.579,217.08,220.581,223.083,227.583,231.579,233.829,241.83,246.834" svgx:width="0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.72,0.28,0.28,0.5,0.25,0.5,0.33,0.28,0.78,0.44,0.33,0.5,0.25,0.5,0.33,0.25,0.39,0.44,0.44,0.5,0.5,0.5,0.44,0.33,0.5,0.25,0.5,0.33,0.5,0.5,0.33,0.44,0.39,0.39,0.28,0.5,0.44,0.25,0.89,0.56,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">patients with primary or secondary progressive MS.</text>
   <text y="154.097" x="62.361,70.857,74.853,77.85,82.854,87.354,92.358,95.859,98.856" svgx:width="0.94,0.44,0.33,0.56,0.5,0.56,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Methods: </text>
   <text y="154.097" x="101.484,106.983,111.483,113.985,117.486,120.114,126.612,130.608,134.109,136.737,140.733,143.361,145.863,152.361,156.861,159.858,164.358,168.858,172.854,176.355,180.351,182.979,186.48,188.982,193.482,197.982,202.482,205.11,209.106,213.606,218.106,221.607,224.109,227.61,230.112,232.614,237.114,241.614,244.242,248.742,251.739,254.367,258.363,260.991,265.491,269.991,273.492,277.488,280.485,283.482,285.984,290.484,294.984" svgx:width="0.61,0.5,0.28,0.39,0.25,0.72,0.44,0.39,0.25,0.44,0.25,0.28,0.72,0.5,0.33,0.5,0.5,0.44,0.39,0.44,0.25,0.39,0.28,0.5,0.5,0.5,0.25,0.44,0.5,0.5,0.39,0.28,0.39,0.28,0.28,0.5,0.5,0.25,0.5,0.33,0.25,0.44,0.25,0.5,0.5,0.39,0.44,0.33,0.33,0.28,0.5,0.5,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">This was a two-phase study consisting of a dose-find-</text>
   <text y="165.095" x="62.361,64.863,69.363,73.863,76.302,80.802,85.302,89.298,92.799,96.795,99.234,103.734,106.236,108.738,111.24,113.742,117.738,120.24,124.74,129.24,131.679,136.179,140.679,144.675,147.672,154.674,158.67,162.666,167.166,171.666,174.168,178.668,182.664,185.166,187.668,191.664,194.661,197.1,201.6,206.1,210.096,213.093,220.095,224.091,228.087,232.587,237.087,241.587,246.087,250.083,257.085,259.587,263.583,266.022,269.019,274.023,280.521,283.518,288.522,295.02,298.017" svgx:width="0.28,0.5,0.5,0.25,0.5,0.5,0.44,0.39,0.44,0.25,0.5,0.28,0.28,0.28,0.28,0.44,0.28,0.5,0.5,0.25,0.5,0.5,0.44,0.33,0.78,0.44,0.44,0.5,0.5,0.28,0.5,0.44,0.28,0.28,0.44,0.33,0.25,0.5,0.5,0.44,0.33,0.78,0.44,0.44,0.5,0.5,0.5,0.5,0.44,0.78,0.28,0.44,0.25,0.33,0.56,0.72,0.33,0.56,0.72,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">ing phase utilizing pharmacokinetic- pharmacodynamic (PK-PD) </text>
   <text y="176.093" x="62.361,69.363,73.863,78.363,82.359,84.861,87.363,91.863,96.363,98.613,99.72,103.716,108.216,112.716,114.966,116.073,120.069,122.319,123.426,125.928,128.925,132.921,136.917,139.419,146.421,150.417,154.917,157.419,159.669,160.776,165.276,169.776,173.772,177.273,181.269,183.519,185.769,186.876,189.873,194.373,196.623,197.73,200.232,204.732,208.728,210.978,212.085,216.585,221.085,224.586,228.582,231.579,234.576,237.078,241.578,246.078,248.58,253.08,257.58,259.83,260.937,265.437,269.937,273.933,277.434,281.43,283.68,285.93,287.037,289.539,294.039,298.035" svgx:width="0.78,0.5,0.5,0.44,0.28,0.28,0.5,0.5,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.44,0.25,0.55,0.28,0.33,0.44,0.44,0.28,0.78,0.44,0.5,0.28,0.25,0.55,0.5,0.5,0.44,0.39,0.44,0.25,0.25,0.55,0.33,0.5,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.5,0.5,0.39,0.44,0.33,0.33,0.28,0.5,0.5,0.28,0.5,0.5,0.25,0.55,0.5,0.5,0.44,0.39,0.44,0.25,0.25,0.55,0.28,0.5,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">modeling and a treatment phase. In the dose-finding phase, the </text>
   <text y="187.091" x="62.361,66.357,69.192,72.189,76.185,80.181,82.683,84.933,86.337,90.837,93.834,96.084,97.488,101.484,105.984,108.234,109.638,113.634,117.135,121.131,125.127,127.629,131.625,134.127,136.629,141.129,145.629,147.879,149.283,153.783,156.78,160.776,163.278,165.528,166.932,171.432,175.932,179.433,183.429,185.679,187.083,191.583,194.58,196.83,198.234,203.733,209.736,214.74,219.24,223.74,228.24,234.243,236.493,237.897,242.397,246.897,249.147,250.551,255.051,259.551,263.547,266.544,273.546,277.542,281.538,286.038,290.538,295.038" svgx:width="0.44,0.33,0.33,0.44,0.44,0.28,0.25,0.55,0.5,0.33,0.25,0.55,0.44,0.5,0.25,0.55,0.44,0.39,0.44,0.44,0.28,0.44,0.28,0.28,0.5,0.5,0.25,0.55,0.5,0.33,0.44,0.28,0.25,0.55,0.5,0.5,0.39,0.44,0.25,0.55,0.5,0.33,0.25,0.55,0.61,0.67,0.56,0.5,0.5,0.5,0.72,0.25,0.55,0.5,0.5,0.25,0.55,0.5,0.5,0.44,0.33,0.78,0.44,0.44,0.5,0.5,0.5,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">effect of an escalating oral dose of ECP002A on pharmacody-</text>
   <text y="198.089" x="62.361,66.861,70.857,77.859,80.361,84.357,87.012,91.512,96.012,98.514,102.51,107.01,114.012,118.008,120.663,125.163,129.159,132.156,134.658,138.654,143.154,145.656,149.652,153.153,155.808,162.306,166.302,169.803,172.458,176.454,179.955,183.456,187.452,190.953,194.454,198.45,202.95,205.605,208.107,212.607,215.262,219.258,221.913,224.91,228.906,233.406,237.906,242.406,249.408,251.91,255.906,259.902,264.402,267.057,271.557,274.059,278.055,282.051,286.047,290.547,295.047" svgx:width="0.5,0.44,0.78,0.28,0.44,0.25,0.5,0.5,0.28,0.44,0.5,0.78,0.44,0.25,0.5,0.44,0.33,0.28,0.44,0.5,0.28,0.44,0.39,0.25,0.72,0.44,0.39,0.25,0.44,0.39,0.39,0.44,0.39,0.39,0.44,0.5,0.25,0.28,0.5,0.25,0.44,0.25,0.33,0.44,0.5,0.5,0.5,0.78,0.28,0.44,0.44,0.5,0.25,0.5,0.28,0.44,0.44,0.44,0.5,0.5,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">namic outcome variables was assessed in a randomized placebo-</text>
   <text y="209.087" x="62.361,66.357,70.857,75.357,77.859,80.856,85.356,87.858,90.36,94.356,98.856,101.106,103.356,104.562,107.064,113.562,118.062,121.059,127.557,131.553,136.053,138.303,139.509,143.505,146.502,151.002,154.503,158.004,161.001,165.501,170.001,173.997,176.994,179.244,180.45,182.952,185.949,188.451,192.447,194.949,197.199,198.405,202.905,206.901,210.402,212.904,217.404,221.904,224.154,226.404,227.61,232.614,236.61,239.112,241.614,245.61,250.11,252.612,256.113,258.363,259.569,264.069,266.571,270.072,272.574,275.076,279.072,283.572,285.822,287.028,289.53,294.03,298.026" svgx:width="0.44,0.5,0.5,0.28,0.33,0.5,0.28,0.28,0.44,0.5,0.25,0.25,0.55,0.28,0.72,0.5,0.33,0.72,0.44,0.5,0.25,0.55,0.44,0.33,0.5,0.39,0.39,0.33,0.5,0.5,0.44,0.33,0.25,0.55,0.28,0.33,0.28,0.44,0.28,0.25,0.55,0.5,0.44,0.39,0.28,0.5,0.5,0.25,0.25,0.55,0.56,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.55,0.5,0.28,0.39,0.28,0.28,0.44,0.5,0.25,0.55,0.28,0.5,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">controlled, two-way cross-over trial design. Patients visited the </text>
   <text y="220.085" x="62.361,66.861,71.361,73.863,78.363,82.359,84.861,87.363,91.359,95.859,98.361,100.602,104.598,107.1,109.602,114.102,116.604,120.6,122.841,127.341,131.841,134.082,136.584,143.082,147.582,149.823,154.323,158.319,162.315,166.311,169.812,172.314,176.814,181.314,184.815,187.056,191.052,195.552,200.052,202.293,205.29,209.286,213.282,217.278,219.78,224.28,228.276,232.776,235.017,239.013,243.513,245.754,249.75,253.251,257.247,261.243,263.745,267.741,270.243,272.745,277.245,281.745,283.986,288.486,291.483,295.479,297.981" svgx:width="0.5,0.5,0.28,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.25,0.44,0.28,0.28,0.5,0.28,0.44,0.25,0.5,0.5,0.25,0.28,0.72,0.5,0.25,0.5,0.44,0.44,0.44,0.39,0.28,0.5,0.5,0.39,0.25,0.44,0.5,0.5,0.25,0.33,0.44,0.44,0.44,0.28,0.5,0.44,0.5,0.25,0.44,0.5,0.25,0.44,0.39,0.44,0.44,0.28,0.44,0.28,0.28,0.5,0.5,0.25,0.5,0.33,0.44,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">outpatient clinic on two occasions and received an escalating oral </text>
   <text y="231.083" x="62.361,66.861,71.361,74.862,78.858,81.693,86.193,89.19,92.025,97.524,103.527,108.531,113.031,117.531,122.031,128.034,130.878,135.378,138.375,141.21,145.71,148.212,152.208,156.204,160.2,164.7,169.2,171.45,174.285,179.289,181.791,185.787,189.288,196.29,200.286,203.121,207.117,211.617,216.117,220.113,224.109,228.609,231.111,234.108,238.104,240.606,243.108,247.608,252.108,255.609,258.444,262.944,265.941,268.281" svgx:width="0.5,0.5,0.39,0.44,0.25,0.5,0.33,0.25,0.61,0.67,0.56,0.5,0.5,0.5,0.72,0.25,0.5,0.33,0.25,0.5,0.28,0.44,0.44,0.44,0.5,0.5,0.25,0.25,0.56,0.28,0.44,0.39,0.78,0.44,0.25,0.44,0.5,0.5,0.44,0.44,0.5,0.28,0.33,0.44,0.28,0.28,0.5,0.5,0.39,0.25,0.5,0.33,0.25,0.64" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">dose of ECP002A or placebo. Plasma concentrations of Δ</text>
   <text y="228.583" x="274.094" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">9</text>
   <text y="231.103" x="277.019,280.016,285.515,292.013,298.016" svgx:width="0.33,0.61,0.72,0.67,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">-THC </text>
   <text y="242.101" x="62.36,66.356,70.856,75.356,77.606,78.821,85.823,89.819,92.321,96.317,100.817,105.317,107.819,110.321,112.823,116.819,120.32,122.57,123.785,130.283,134.279,137.276,141.272,143.522,144.737,151.739,155.735,159.731,163.232,167.732,170.729,174.725,179.225,181.475,182.69,185.192,189.692,191.942,193.157,197.657,201.653,206.153,210.149,213.146,217.142,219.644,223.64,225.89,227.105,231.101,235.601,237.851,239.066,241.568,246.068,250.568,253.07,257.57,260.072,264.572,269.072,273.068,275.57,277.82,279.035,281.537,284.534,288.53,292.526,295.028" svgx:width="0.44,0.5,0.5,0.25,0.55,0.78,0.44,0.28,0.44,0.5,0.5,0.28,0.28,0.28,0.44,0.39,0.25,0.55,0.72,0.44,0.33,0.44,0.25,0.55,0.78,0.44,0.44,0.39,0.5,0.33,0.44,0.5,0.25,0.55,0.28,0.5,0.25,0.55,0.5,0.44,0.5,0.44,0.33,0.44,0.28,0.44,0.25,0.55,0.44,0.5,0.25,0.55,0.28,0.5,0.5,0.28,0.5,0.28,0.5,0.5,0.44,0.28,0.25,0.55,0.28,0.33,0.44,0.44,0.28,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">and metabolites were measured to generate an individual treat-</text>
   <text y="253.099" x="62.36,69.362,73.358,77.858,80.36,82.61,84.5,87.497,91.493,95.993,98.495,105.497,109.493,113.993,116.243,118.133,122.633,126.629,130.13,134.126,138.626,140.876,142.766,147.266,151.766,154.016,155.906,160.91,167.408,169.658,171.548,175.544,180.044,184.544,186.794,188.684,193.688,200.186,202.436,204.686,206.576,209.573,214.073,216.323,218.213,220.715,225.215,229.211,231.461,233.351,237.851,240.848,247.346,251.342,255.338,259.838,262.088,263.978,266.48,269.477,273.473,277.469,279.971,286.973,290.969,295.469,297.971" svgx:width="0.78,0.44,0.5,0.28,0.25,0.55,0.33,0.44,0.5,0.28,0.78,0.44,0.5,0.25,0.55,0.5,0.44,0.39,0.44,0.5,0.25,0.55,0.5,0.5,0.25,0.55,0.56,0.72,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.56,0.72,0.25,0.25,0.55,0.33,0.5,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.5,0.33,0.72,0.44,0.44,0.5,0.25,0.55,0.28,0.33,0.44,0.44,0.28,0.78,0.44,0.5,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">ment regimen based on PK and PD. In the 4-week treatment </text>
   <text y="264.097" x="62.36,66.86,71.36,75.356,78.857,82.853,85.103,87.299,89.801,94.301,98.297,100.493,102.995,107.495,111.995,114.497,118.997,121.499,125.999,130.499,134.495,136.997,139.193,143.693,148.193,151.694,155.69,157.886,164.384,168.38,171.881,174.077,178.073,182.573,189.575,192.077,196.577,199.079,202.58,205.082,209.078,212.075,216.071,220.571,222.767,225.269,229.769,232.766,236.762,240.758,242.954,245.456,247.958,254.96,258.956,262.457,264.653,269.153,273.149,275.651,278.153,282.653,284.849,287.351,291.851,294.047,298.043" svgx:width="0.5,0.5,0.44,0.39,0.44,0.25,0.25,0.28,0.5,0.44,0.25,0.28,0.5,0.5,0.28,0.5,0.28,0.5,0.5,0.44,0.28,0.25,0.5,0.5,0.39,0.44,0.25,0.72,0.44,0.39,0.25,0.44,0.5,0.78,0.28,0.5,0.28,0.39,0.28,0.44,0.33,0.44,0.5,0.25,0.28,0.5,0.33,0.44,0.44,0.25,0.28,0.28,0.78,0.44,0.39,0.25,0.5,0.44,0.28,0.28,0.5,0.25,0.28,0.5,0.25,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">phase, the individual dose was administered three times daily in a </text>
   <text y="275.095" x="62.36,65.357,69.353,73.853,78.353,82.853,89.855,92.357,96.353,100.349,104.849,106.883,111.383,113.885,117.881,121.877,125.873,130.373,134.873,137.87,141.866,146.366,150.866,153.368,156.365,160.865,163.367,165.869,169.865,174.365,176.615,178.649,183.149,187.145,190.142,194.138,196.64,199.142,203.138,205.64,207.674,210.671,214.667,218.168,222.668,225.17,229.67,234.17,236.42,238.454,244.952,249.452,252.449,254.951,259.451,263.951,265.985,268.487,272.987,276.983,279.017,281.519,284.516,288.512,292.508,295.01" svgx:width="0.33,0.44,0.5,0.5,0.5,0.78,0.28,0.44,0.44,0.5,0.25,0.5,0.28,0.44,0.44,0.44,0.5,0.5,0.33,0.44,0.5,0.5,0.28,0.33,0.5,0.28,0.28,0.44,0.5,0.25,0.25,0.5,0.44,0.33,0.44,0.28,0.28,0.44,0.28,0.25,0.33,0.44,0.39,0.5,0.28,0.5,0.5,0.25,0.25,0.72,0.5,0.33,0.28,0.5,0.5,0.25,0.28,0.5,0.44,0.25,0.28,0.33,0.44,0.44,0.28,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">randomized placebo-controlled, parallel fashion. During the treat-</text>
   <text y="286.093" x="62.36,69.362,73.358,77.858,80.36,82.61,83.528,88.028,92.528,96.524,100.025,104.021,106.271,107.189,114.191,118.691,122.192,126.188,128.69,132.686,134.936,135.854,139.355,143.855,147.851,151.352,153.854,156.356,160.352,162.854,165.356,169.856,172.106,173.024,176.021,182.519,186.02,190.52,197.018,201.518,204.515,207.017,211.517,213.767,214.685,218.681,223.181,227.681,229.931,230.849,234.35,238.85,243.35,245.852,249.848,253.844,256.346,258.848,263.348,267.344,269.594,270.512,274.013,278.513,282.509,286.01,288.512,291.014,295.01" svgx:width="0.78,0.44,0.5,0.28,0.25,0.55,0.5,0.5,0.44,0.39,0.44,0.25,0.55,0.78,0.5,0.39,0.44,0.28,0.44,0.25,0.55,0.39,0.5,0.44,0.39,0.28,0.28,0.44,0.28,0.28,0.5,0.25,0.55,0.33,0.72,0.39,0.5,0.72,0.5,0.33,0.28,0.5,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.39,0.5,0.5,0.28,0.44,0.44,0.28,0.28,0.5,0.44,0.25,0.55,0.39,0.5,0.44,0.39,0.28,0.28,0.44,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">ment phase muscle spasticity (Ashworth and subjective spastic-</text>
   <text y="297.091" x="62.36,64.862,67.364,71.864,74.861,77.111,79.361,80.657,85.157,89.153,91.655,96.155,98.405,99.701,103.697,108.197,112.697,114.947,116.243,120.239,122.741,125.243,129.743,132.245,136.241,140.237,142.739,144.989,146.285,150.785,155.285,157.787,161.783,166.283,173.285,177.281,180.782,183.032,184.328,187.325,191.321,193.571,198.071,200.321,202.571,203.867,209.366,215.864,220.868,225.872,228.122,230.372,231.668,236.168,240.668,245.672,248.174,250.424,251.558,256.742,259.244,266.246,270.242,274.742,276.992,278.288,284.786,288.782,291.284,295.784,298.034" svgx:width="0.28,0.28,0.5,0.33,0.25,0.25,0.55,0.5,0.44,0.28,0.5,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.44,0.28,0.28,0.5,0.28,0.44,0.44,0.28,0.25,0.55,0.5,0.5,0.28,0.44,0.5,0.78,0.44,0.39,0.25,0.55,0.33,0.44,0.25,0.5,0.25,0.25,0.55,0.61,0.72,0.56,0.56,0.25,0.25,0.55,0.5,0.5,0.56,0.28,0.25,0.55,0.61,0.28,0.78,0.44,0.5,0.25,0.55,0.72,0.44,0.28,0.5,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">ity), pain and clinical outcomes (e.g. EDSS, 25Ft Timed walk, </text>
   <text y="308.089" x="62.36,68.858,75.356,81.854,86.858,89.855,92.105,98.603,102.599,105.596,109.592,111.842,118.844,122.84,126.836,130.337,134.837,137.834,141.83,146.33,148.58,152.576,155.078,157.328,161.828,165.824,169.325,173.321,175.823,178.325,182.825,186.821,189.071,191.321,197.819,201.815,205.811,210.311,212.561,217.061,219.311,223.307,227.807,232.307,234.557,239.057" svgx:width="0.72,0.72,0.72,0.56,0.33,0.25,0.72,0.44,0.33,0.44,0.25,0.78,0.44,0.44,0.39,0.5,0.33,0.44,0.5,0.25,0.44,0.28,0.25,0.5,0.44,0.39,0.44,0.28,0.28,0.5,0.44,0.25,0.25,0.72,0.44,0.44,0.5,0.25,0.5,0.25,0.44,0.5,0.5,0.25,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">GNDS) were measured at baseline, week 2 and 4.</text>
   <text y="319.087" x="62.36,68.858,72.854,76.355,81.359,83.861,86.858,90.359,93.356" svgx:width="0.72,0.44,0.39,0.56,0.28,0.33,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Results: </text>
   <text y="319.087" x="96.173,101.177,105.173,107.675,112.175,114.992,121.49,125.486,128.987,131.804,135.305,137.807,142.307,146.807,149.309,152.306,154.808,158.804,162.8,167.3,169.802,172.304,176.804,179.621,182.618,186.614,191.114,195.614,199.61,203.606,208.106,210.923,217.421,221.921,225.917,230.417,233.234,240.236,244.232,248.228,251.729,256.229,259.226,263.222,267.722,270.539,275.039,277.541,280.538,284.534,288.53,291.032,293.534,298.034" svgx:width="0.56,0.44,0.28,0.5,0.25,0.72,0.44,0.39,0.25,0.39,0.28,0.5,0.5,0.28,0.33,0.28,0.44,0.44,0.5,0.28,0.28,0.5,0.25,0.33,0.44,0.5,0.5,0.44,0.44,0.5,0.25,0.72,0.5,0.44,0.5,0.25,0.78,0.44,0.44,0.39,0.5,0.33,0.44,0.5,0.25,0.5,0.28,0.33,0.44,0.44,0.28,0.28,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Pain was significantly reduced when measured directly </text>
   <text y="330.085" x="62.36,66.356,69.353,71.855,75.851,78.848,80.792,84.788,89.288,96.29,98.792,103.292,105.794,109.295,111.797,114.794,118.79,121.292,123.794,128.294,132.794,134.738,139.238,142.235,144.179,149.678,155.681,160.685,165.185,169.685,174.185,180.188,182.132,184.634,189.134,191.078,193.58,198.08,202.076,204.02,208.016,210.518,213.02,217.52,220.022,224.018,226.268,228.212,232.712,237.212,239.714,241.658,246.158,250.658,253.16,255.104,261.602,266.102,270.098,274.598,276.542,283.544,287.54,291.536,295.037" svgx:width="0.44,0.33,0.28,0.44,0.33,0.25,0.44,0.5,0.78,0.28,0.5,0.28,0.39,0.28,0.33,0.44,0.28,0.28,0.5,0.5,0.25,0.5,0.33,0.25,0.61,0.67,0.56,0.5,0.5,0.5,0.72,0.25,0.28,0.5,0.25,0.28,0.5,0.44,0.25,0.44,0.28,0.28,0.5,0.28,0.44,0.25,0.25,0.5,0.5,0.28,0.25,0.5,0.5,0.28,0.25,0.72,0.5,0.44,0.5,0.25,0.78,0.44,0.44,0.39,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">after administration of ECP002A in the clinic, but not when meas-</text>
   <text y="341.083" x="62.36,66.86,69.857,73.853,78.353,80.63,83.132,87.632,89.909,93.905,96.182,100.682,104.678,107.18,109.682,114.182,116.459,120.959,123.461,127.457,130.454,134.369,136.619,138.401,144.404,146.681,150.182,152.684,159.686,162.188,164.69,168.686,171.683,173.96,178.46,182.456,184.958,187.46,191.456,194.453,198.953,201.23,207.728,211.724,215.225,217.502,222.002,226.502,230.003,233.999,236.996,241.496,245.492,249.992,252.269,254.771,259.271,261.548,265.049,269.549,274.049,276.551,280.547,284.543,287.045,289.547,294.047,298.043" svgx:width="0.5,0.33,0.44,0.5,0.25,0.28,0.5,0.25,0.44,0.25,0.5,0.44,0.28,0.28,0.5,0.25,0.5,0.28,0.44,0.33,0.5,0.25,0.25,0.72,0.25,0.39,0.28,0.78,0.28,0.28,0.44,0.33,0.25,0.5,0.44,0.28,0.28,0.44,0.33,0.5,0.25,0.72,0.44,0.39,0.25,0.5,0.5,0.39,0.44,0.33,0.5,0.44,0.5,0.25,0.28,0.5,0.25,0.39,0.5,0.5,0.28,0.44,0.44,0.28,0.28,0.5,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">ured in a daily diary. A similar pattern was observed in subjective </text>
   <text y="352.081" x="62.36,69.362,73.862,77.363,81.359,83.861,87.857,90.575,94.076,98.576,102.572,106.073,108.575,111.077,115.073,117.575,120.077,123.992,126.242,128.96,135.458,137.96,142.46,146.456,149.453,152.171,156.167,158.669,161.171,165.671,168.173,172.169,176.165,178.667,181.385,185.885,190.385,192.887,196.883,201.383,208.385,212.381,215.882,218.6,225.098,229.094,232.091,236.087,238.805,243.305,247.805,250.307,253.025,256.526,259.028,263.528,268.028,270.53,273.527,276.029,280.025,284.021,288.521,291.023,293.525,298.025" svgx:width="0.78,0.5,0.39,0.44,0.28,0.44,0.25,0.39,0.5,0.44,0.39,0.28,0.28,0.44,0.28,0.28,0.5,0.25,0.25,0.72,0.28,0.5,0.44,0.33,0.25,0.44,0.28,0.28,0.5,0.28,0.44,0.44,0.28,0.25,0.5,0.5,0.28,0.44,0.5,0.78,0.44,0.39,0.25,0.72,0.44,0.33,0.44,0.25,0.5,0.5,0.28,0.25,0.39,0.28,0.5,0.5,0.28,0.33,0.28,0.44,0.44,0.5,0.28,0.28,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">muscle spasticity. Other clinical outcomes were not significantly </text>
   <text y="363.079" x="62.36,66.86,69.362,72.197,75.194,79.19,82.187,86.183,90.683,93.185,95.561,100.061,104.057,106.559,113.057,117.053,121.049,125.549,127.925,131.921,135.917,138.419,140.921,145.421,149.417,151.793,154.295,157.292,161.288,165.284,167.786,174.788,178.784,183.284,185.786,188.162,192.158,196.658,201.158,203.534,208.034,210.536,214.532,218.528,222.524,227.024,231.524,233.774,236.15,242.153,246.653,251.153,255.653,258.155,260.657,263.159,267.659,271.655,274.031,276.533,280.529,284.03,286.532,289.034,293.534,298.034" svgx:width="0.5,0.28,0.33,0.33,0.44,0.33,0.44,0.5,0.28,0.25,0.5,0.44,0.28,0.72,0.44,0.44,0.5,0.25,0.44,0.44,0.28,0.28,0.5,0.44,0.25,0.28,0.33,0.44,0.44,0.28,0.78,0.44,0.5,0.28,0.25,0.44,0.5,0.5,0.25,0.5,0.28,0.44,0.44,0.44,0.5,0.5,0.25,0.25,0.67,0.5,0.5,0.5,0.28,0.28,0.28,0.5,0.44,0.25,0.28,0.44,0.39,0.28,0.28,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">different between active treatment and placebo. Cognitive testing </text>
   <text y="374.077" x="62.36,64.862,69.362,73.862,76.364,80.36,84.356,86.858,90.854,95.354,97.991,100.493,104.993,108.989,111.986,115.982,118.628,125.126,129.122,132.623,135.26,139.76,144.26,146.906,151.406,155.402,159.398,161.9,164.402,168.902,172.898,175.535,178.037,182.537,185.183,189.179,193.679,198.179,202.679,205.181,207.683,210.185,214.685,219.185,221.831,225.827,228.824,231.326,235.322,238.319,240.956,245.456,248.102,252.602,255.599,258.245,262.745,265.382,271.88,275.876,279.872,284.372,287.873,290.519,295.019,298.016" svgx:width="0.28,0.5,0.5,0.28,0.44,0.44,0.28,0.44,0.5,0.25,0.28,0.5,0.44,0.33,0.44,0.25,0.72,0.44,0.39,0.25,0.5,0.5,0.25,0.5,0.44,0.44,0.28,0.28,0.5,0.44,0.25,0.28,0.5,0.25,0.44,0.5,0.5,0.5,0.28,0.28,0.28,0.5,0.5,0.25,0.44,0.33,0.28,0.44,0.33,0.25,0.5,0.25,0.5,0.33,0.25,0.5,0.25,0.72,0.44,0.44,0.5,0.39,0.25,0.5,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">indicated there was no decline in cognition after 2 or 4 weeks of </text>
   <text y="385.075" x="62.36,64.862,67.859,71.855,75.851,78.353,85.355,89.351,93.851,96.353,98.603,103.103,107.603,111.599,113.849,116.351,120.851,123.101,128.6,134.603,139.607,144.107,148.607,153.107,159.11,161.36,165.356,169.856,176.858,181.358,185.354,188.351,192.347,196.847,199.097,201.599,206.099,208.349,212.849,215.351,219.347,223.343,227.339,231.839,236.339" svgx:width="0.28,0.33,0.44,0.44,0.28,0.78,0.44,0.5,0.28,0.25,0.5,0.5,0.44,0.25,0.28,0.5,0.25,0.61,0.67,0.56,0.5,0.5,0.5,0.72,0.25,0.44,0.5,0.78,0.5,0.44,0.33,0.44,0.5,0.25,0.28,0.5,0.25,0.5,0.28,0.44,0.44,0.44,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">treatment due to ECP002A compared to placebo.</text>
   <text y="396.073" x="62.36,68.858,73.358,78.362,82.358,84.86,89.864,93.365,95.867,100.367,105.371,108.872,111.869" svgx:width="0.72,0.5,0.56,0.44,0.28,0.56,0.39,0.28,0.5,0.56,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Conclusions: </text>
   <text y="396.073" x="114.596,120.095,126.098,131.102,135.602,140.102,144.602,150.605,153.332,157.328,161.828,166.328,170.324,174.32,177.317,180.818,183.545,186.047,190.547,193.274,197.774,201.77,204.497,208.493,211.328,214.325,218.321,222.317,224.819,227.321,231.821,235.817,238.544,241.046,245.546,248.273,251.27,255.266,259.766,264.266,268.262,270.764,275.264,279.764,282.491,285.992,290.492,294.992" svgx:width="0.61,0.67,0.56,0.5,0.5,0.5,0.72,0.25,0.44,0.5,0.5,0.44,0.44,0.33,0.39,0.25,0.28,0.5,0.25,0.5,0.44,0.25,0.44,0.33,0.33,0.44,0.44,0.28,0.28,0.5,0.44,0.25,0.28,0.5,0.25,0.33,0.44,0.5,0.5,0.44,0.28,0.5,0.5,0.25,0.39,0.5,0.5,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">ECP002A appears to be effective in reducing sub-</text>
   <text y="407.071" x="62.36,64.862,68.858,72.854,75.356,77.858,82.358,86.354,88.559,92.06,96.56,103.562,108.062,110.564,115.064,122.066,125.567,127.772,130.274,134.774,138.77,141.272,145.772,150.272,152.774,157.274,161.774,163.979,170.981,175.481,178.982,182.978,185.48,189.476,191.681,195.182,199.682,203.678,207.179,209.681,212.183,216.179,218.681,221.183,225.683,227.888,231.884,236.384,240.884,243.089,247.589,251.585,254.087,258.587,260.792,263.294,267.794,269.999,274.499,278.495,280.997,283.499,287.495,291.995,294.497,297.998" svgx:width="0.28,0.44,0.44,0.28,0.28,0.5,0.44,0.25,0.39,0.5,0.78,0.5,0.28,0.5,0.78,0.39,0.25,0.28,0.5,0.44,0.28,0.5,0.5,0.28,0.5,0.5,0.25,0.78,0.5,0.39,0.44,0.28,0.44,0.25,0.39,0.5,0.44,0.39,0.28,0.28,0.44,0.28,0.28,0.5,0.25,0.44,0.5,0.5,0.25,0.5,0.44,0.28,0.5,0.25,0.28,0.5,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">jective symptoms including muscle spasticity and pain in patients </text>
   <text y="418.069" x="62.36,65.861,70.361,73.196,76.193,80.189,83.186,85.688,90.188,94.688,96.938,97.982,100.979,103.976,108.476,115.478,117.728,118.772,126.773,131.777,134.027,135.071,141.569,146.069,150.065,154.565,156.815,157.859,164.861,168.857,172.853,176.354,180.854,183.851,187.847,192.347,194.597,195.641,198.143,205.145,212.147,216.143,220.643,223.145,227.141,229.643,233.639,236.141,240.641,242.891,243.935,247.931,250.928,253.43,257.426,260.423,262.673,263.717,268.217,272.717,276.218,278.72,283.22,287.72,289.97,291.014,293.516,298.016" svgx:width="0.39,0.5,0.33,0.33,0.44,0.33,0.28,0.5,0.5,0.25,0.55,0.33,0.33,0.5,0.78,0.25,0.55,0.89,0.56,0.25,0.55,0.72,0.5,0.44,0.5,0.25,0.55,0.78,0.44,0.44,0.39,0.5,0.33,0.44,0.5,0.25,0.55,0.28,0.78,0.78,0.44,0.5,0.28,0.44,0.28,0.44,0.28,0.5,0.25,0.55,0.44,0.33,0.28,0.44,0.33,0.25,0.55,0.5,0.5,0.39,0.28,0.5,0.5,0.25,0.55,0.28,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">suffering from MS when measured immediately after dosing in </text>
   <text y="429.067" x="62.36,64.862,69.362,73.358,76.238,80.234,82.736,85.238,89.738,92.24,96.236,98.486,101.204,106.703,111.203,113.705,117.206,120.086,124.082,126.917,129.914,133.91,137.906,140.408,143.288,147.284,151.784,156.284,158.786,163.286,166.166,170.666,175.166,177.668,180.548,185.048,189.044,191.924,195.425,199.925,204.425,210.923,215.423,218.303,224.801,229.301,233.297,237.797,240.677,247.679,251.675,255.671,259.172,263.672,266.669,270.665,275.165,278.045,281.042,285.038,287.54,290.537,295.037" svgx:width="0.28,0.5,0.44,0.25,0.44,0.28,0.28,0.5,0.28,0.44,0.25,0.25,0.61,0.5,0.28,0.39,0.25,0.44,0.33,0.33,0.44,0.44,0.28,0.25,0.44,0.5,0.5,0.28,0.5,0.25,0.5,0.5,0.28,0.25,0.5,0.44,0.25,0.39,0.5,0.5,0.72,0.5,0.25,0.72,0.5,0.44,0.5,0.25,0.78,0.44,0.44,0.39,0.5,0.33,0.44,0.5,0.25,0.33,0.44,0.28,0.33,0.5,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">the clinic. This effect could not be shown when measured retro-</text>
   <text y="440.065" x="62.36,65.861,70.361,74.357,78.353,80.855,83.357,87.857,91.853,94.355,98.855,101.105,105.605,109.106,111.608,116.108,120.608,122.858,126.854,129.104,133.604,136.106,140.102,143.099,147.014" svgx:width="0.39,0.5,0.44,0.44,0.28,0.28,0.5,0.44,0.28,0.5,0.25,0.5,0.39,0.28,0.5,0.5,0.25,0.44,0.25,0.5,0.28,0.44,0.33,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">spectively using a diary.</text>
   <text y="472.069" x="62.36,67.859,72.359,76.859" svgx:width="0.61,0.5,0.5,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">P943</text>
   <text y="483.067" x="62.36,69.362,73.358,76.355,80.351,84.347,88.847,93.347,97.343,102.347,106.343,110.843,115.847,119.348,121.598,125.594,128.591,131.093,135.593,138.095,142.595,147.095,151.595,153.845,158.345,161.342,163.592,166.589,171.089,174.086,176.588,181.088,186.092,190.088,192.338,195.839,200.339,205.343,210.347,214.343,218.843,226.34,230.336,232.586,235.088,240.092,242.342,249.839,254.843,257.345,260.342,262.844,267.848,270.35,274.346" svgx:width="0.78,0.44,0.33,0.44,0.44,0.5,0.5,0.44,0.56,0.44,0.5,0.56,0.39,0.25,0.44,0.33,0.28,0.5,0.28,0.5,0.5,0.5,0.25,0.5,0.33,0.25,0.33,0.5,0.33,0.28,0.5,0.56,0.44,0.25,0.39,0.5,0.56,0.56,0.44,0.5,0.83,0.44,0.25,0.28,0.56,0.25,0.83,0.56,0.28,0.33,0.28,0.56,0.28,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Heterogeneous etiology of fatigue syndrome in multiple </text>
   <text y="494.065" x="62.36,65.861,69.857,72.359,76.355,80.351,84.851,88.352,90.854,94.355,96.605,101.609,106.109,109.106,111.608,115.604,120.608,123.605" svgx:width="0.39,0.44,0.28,0.44,0.44,0.5,0.39,0.28,0.39,0.25,0.56,0.5,0.33,0.28,0.44,0.56,0.33,0.39" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">sclerosis patients</text>
   <text y="505.063" x="62.36,68.858,71.108,76.112,80.612,85.112,87.614,91.61,95.606,100.106,104.102,107.099,112.103,114.605,118.601,121.103,125.603,132.101,135.602,140.102" svgx:width="0.72,0.25,0.56,0.5,0.5,0.28,0.44,0.44,0.5,0.44,0.33,0.56,0.28,0.44,0.28,0.5,0.72,0.39,0.5,0.44" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">A Podlecka-Piętowska</text>
   <text y="502.583" x="144.099" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="505.103" x="147.024,149.274,151.524,156.528,158.778,163.782,167.778,172.278,178.776,182.772,185.769,189.27,193.77" svgx:width="0.25,0.25,0.56,0.25,0.56,0.44,0.5,0.72,0.44,0.33,0.39,0.5,0.44" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, S Szuwarska</text>
   <text y="502.583" x="197.765" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="505.103" x="200.69,202.94,205.19,213.191,215.441,221.939,226.439,228.941,232.442,236.438,240.434,246.932,250.433,254.933" svgx:width="0.25,0.25,0.89,0.25,0.72,0.5,0.28,0.39,0.44,0.44,0.72,0.39,0.5,0.44" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, M Nojszewska</text>
   <text y="502.583" x="258.929" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="505.103" x="261.854,264.104,266.354,272.357" svgx:width="0.25,0.25,0.67,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, B </text>
   <text y="516.101" x="62.36,67.859,71.855,76.355,79.352,83.348,87.344,93.842,97.343,101.843,105.839,108.836,113.84,118.34,120.842,124.838,131.336,134.837,139.337" svgx:width="0.61,0.44,0.5,0.33,0.44,0.44,0.72,0.39,0.5,0.44,0.33,0.56,0.5,0.28,0.44,0.72,0.39,0.5,0.44" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Zakrzewska-Pniewska</text>
   <text y="513.583" x="143.334" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="524.581" x="62.364" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:5.85px;stroke:none;">1</text>
   <text y="527.103" x="65.287,72.784,76.78,81.28,83.782,87.778,92.278,94.78,97.03,103.528,108.028,110.53,114.526,118.522,122.023,125.524,128.026,130.528,134.524,136.774,141.274,143.776,146.026,153.523,158.023,161.524,165.025,169.525,175.528,177.778,180.028,186.526,190.522,195.022,199.522,203.023,205.525,212.023,216.019,220.519,223.021,225.271,229.771,232.273,234.523,240.526,244.522,249.022,252.523,257.023,259.525,264.025,268.525,272.521,274.771" svgx:width="0.83,0.44,0.5,0.28,0.44,0.5,0.28,0.25,0.72,0.5,0.28,0.44,0.44,0.39,0.39,0.28,0.28,0.44,0.25,0.5,0.28,0.25,0.83,0.5,0.39,0.39,0.5,0.67,0.25,0.25,0.72,0.44,0.5,0.5,0.39,0.28,0.72,0.44,0.5,0.28,0.25,0.5,0.28,0.25,0.67,0.44,0.5,0.39,0.5,0.28,0.5,0.5,0.44,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Medical University of Warsaw, Department of Neurology, </text>
   <text y="538.101" x="62.362,69.859,74.359,77.86,81.361,85.861,91.864,94.114,96.364,101.863,106.363,108.865,113.365,117.865" svgx:width="0.83,0.5,0.39,0.39,0.5,0.67,0.25,0.25,0.61,0.5,0.28,0.5,0.5,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Warsaw, Poland</text>
   <text y="565.101" x="62.362,68.365,72.865,76.861,81.865,86.365,90.199,94.699,99.703,104.707,109.711,112.708" svgx:width="0.67,0.5,0.44,0.56,0.5,0.44,0.5,0.56,0.56,0.56,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Background: </text>
   <text y="565.101" x="115.579,120.583,124.579,127.081,129.583,134.083,138.583,142.579,145.45,147.952,151.453,154.324,158.824,163.324,167.32,170.191,174.691,177.688,180.559,183.061,187.561,191.557,194.428,201.43,205.93,209.431,211.933,214.804,218.8,223.3,230.302,237.304,241.804,246.304,249.175,253.171,257.671,262.171,265.042,269.542,272.044,275.545,279.541,284.041,286.543,289.045,293.545,298.045" svgx:width="0.56,0.44,0.28,0.28,0.5,0.5,0.44,0.25,0.28,0.39,0.25,0.5,0.5,0.44,0.25,0.5,0.33,0.25,0.28,0.5,0.44,0.25,0.78,0.5,0.39,0.28,0.25,0.44,0.5,0.78,0.78,0.5,0.5,0.25,0.44,0.5,0.5,0.25,0.5,0.28,0.39,0.44,0.5,0.28,0.28,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Fatigue is one of the most common and disabling </text>
   <text y="576.099" x="62.362,65.863,70.363,77.365,81.865,84.367,88.867,95.869,99.37,101.62,102.673,105.175,109.675,111.925,112.978,119.98,124.48,126.982,129.484,131.986,136.486,138.988,142.984,145.234,146.287,149.788,153.784,156.286,160.282,163.279,167.779,171.28,173.782,177.283,179.533,180.586,183.583,191.584,196.588,199.585,201.835,204.085,205.138,208.135,210.637,212.887,213.94,217.936,221.932,226.432,228.682,229.735,234.235,237.232,241.732,244.729,249.229,253.729,258.229,262.729,265.231,269.731,271.981,273.034,277.534,280.036,283.537,286.534,291.034,295.534,298.036" svgx:width="0.39,0.5,0.78,0.5,0.28,0.5,0.78,0.39,0.25,0.55,0.28,0.5,0.25,0.55,0.78,0.5,0.28,0.28,0.28,0.5,0.28,0.44,0.25,0.55,0.39,0.44,0.28,0.44,0.33,0.5,0.39,0.28,0.39,0.25,0.55,0.33,0.89,0.56,0.33,0.25,0.25,0.55,0.33,0.28,0.25,0.55,0.44,0.44,0.5,0.25,0.55,0.5,0.33,0.5,0.33,0.5,0.5,0.5,0.5,0.28,0.5,0.25,0.55,0.5,0.28,0.39,0.33,0.5,0.5,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">symptoms in multiple sclerosis (MS). It can profoundly disrupt </text>
   <text y="587.097" x="62.362,64.864,69.364,73.36,75.331,79.831,83.827,87.823,92.323,96.823,100.819,103.321,105.823,110.323,114.823,118.819,121.321,123.292,127.288,131.788,136.288,138.259,141.76,146.26,150.256,152.758,156.754,159.256,161.227,164.224,168.724,173.224,177.22,179.722,182.224,186.724,191.224,193.726,198.226,202.726,204.697,209.197,212.194,214.165,218.665,222.661,225.163,227.665,231.661,236.161,238.663,242.164,244.135,248.131,252.631,257.131,259.102,263.602,267.598,272.098,276.094,278.065,282.061,284.032,288.532,292.528,295.03" svgx:width="0.28,0.5,0.44,0.25,0.5,0.44,0.44,0.5,0.5,0.44,0.28,0.28,0.5,0.5,0.44,0.28,0.25,0.44,0.5,0.5,0.25,0.39,0.5,0.44,0.28,0.44,0.28,0.25,0.33,0.5,0.5,0.44,0.28,0.28,0.5,0.5,0.28,0.5,0.5,0.25,0.5,0.33,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.44,0.5,0.5,0.25,0.5,0.44,0.5,0.44,0.25,0.44,0.25,0.5,0.44,0.28,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">the occupational and social functioning of patients and have a det-</text>
   <text y="598.095" x="62.362,65.359,67.861,74.863,78.859,83.359,85.861,89.857,92.359,94.609,95.734,99.73,102.565,105.562,109.558,113.554,116.056,118.306,119.431,123.931,128.431,130.681,131.806,134.308,138.808,142.804,145.306,148.303,150.553,151.678,156.178,160.678,164.674,167.176,169.678,172.18,176.68,178.93,180.055,184.555,187.552,189.802,190.927,193.429,195.931,198.928,202.924,205.174,207.424,208.387,213.886,218.386,222.382,224.632,225.757,229.753,232.255,234.757,239.257,241.759,246.259,250.759,255.259,257.509,258.634,262.63,267.13,271.63,273.88,275.005,279.505,283.501,286.003,290.503,295.003" svgx:width="0.33,0.28,0.78,0.44,0.5,0.28,0.44,0.28,0.25,0.55,0.44,0.33,0.33,0.44,0.44,0.28,0.25,0.55,0.5,0.5,0.25,0.55,0.28,0.5,0.44,0.28,0.33,0.25,0.55,0.5,0.5,0.44,0.28,0.28,0.28,0.5,0.25,0.55,0.5,0.33,0.25,0.55,0.28,0.28,0.33,0.44,0.25,0.25,0.55,0.61,0.5,0.44,0.25,0.55,0.44,0.28,0.28,0.5,0.28,0.5,0.5,0.5,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.5,0.44,0.28,0.5,0.5,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">rimental effect on their quality of life. The etiology and patho-</text>
   <text y="609.093" x="62.362,66.862,71.362,75.862,79.363,81.865,86.365,88.867,93.367,97.867,102.367,104.617,109.117,112.114,114.364,122.365,127.369,130.366,133.363,137.359,139.861,143.857,146.359,150.355,154.855,157.105,160.102,164.098,166.6,169.102,173.602,178.102,182.098,184.348,187.345,191.341,198.343,202.339,204.841,209.341,212.842,215.092,219.592,224.092,228.592,233.092,237.592,244.09,248.59" svgx:width="0.5,0.5,0.5,0.39,0.28,0.5,0.28,0.5,0.5,0.5,0.25,0.5,0.33,0.25,0.89,0.56,0.33,0.33,0.44,0.28,0.44,0.28,0.44,0.5,0.25,0.33,0.44,0.28,0.28,0.5,0.5,0.44,0.25,0.33,0.44,0.78,0.44,0.28,0.5,0.39,0.25,0.5,0.5,0.5,0.5,0.5,0.72,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">physiology of MS-related fatigue remains unknown.</text>
   <text y="620.091" x="62.362,69.364,74.368,77.365,81.361,85.357,88.354,90.856,95.356,99.352,102.853,105.85" svgx:width="0.78,0.56,0.33,0.44,0.44,0.33,0.28,0.5,0.44,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Objectives: </text>
   <text y="620.091" x="109.171,114.67,119.17,123.166,125.416,126.487,130.483,132.985,139.987,142.237,143.308,147.808,150.805,153.055,154.126,156.628,161.128,163.63,167.131,169.381,170.452,173.953,176.455,180.955,185.455,189.955,192.205,193.276,199.774,203.77,207.271,209.521,210.592,213.094,217.594,219.844,220.915,224.911,229.411,233.407,235.909,240.409,244.405,246.907,250.903,253.153,254.224,257.221,261.217,263.719,266.221,270.721,275.221,279.217,281.467,282.538,286.039,290.539,295.039" svgx:width="0.61,0.5,0.44,0.25,0.55,0.44,0.28,0.78,0.25,0.55,0.5,0.33,0.25,0.55,0.28,0.5,0.28,0.39,0.25,0.55,0.39,0.28,0.5,0.5,0.5,0.25,0.55,0.72,0.44,0.39,0.25,0.55,0.28,0.5,0.25,0.55,0.44,0.5,0.44,0.28,0.5,0.44,0.28,0.44,0.25,0.55,0.33,0.44,0.28,0.28,0.5,0.5,0.44,0.25,0.55,0.39,0.5,0.5,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">The aim of this study was to evaluate fatigue syn-</text>
   <text y="631.089" x="62.362,66.862,69.859,74.359,81.361,85.357,87.751,90.253,94.753,97.147,101.647,105.643,108.64,111.142,115.642,120.142,123.643,126.037,130.033,132.535,135.037,139.537,142.039,146.035,150.031,152.533,154.927,159.427,163.927,167.923,172.423,176.923,179.425,183.925,188.425,192.421,195.922,198.316,202.816,205.813,208.207,216.208,221.212,223.606,227.602,232.102,236.602,238.996,241.498,245.998,248.392,251.893,254.395,258.895,263.395,267.895,270.289,272.791,277.291,281.287,283.681,287.677,292.177,295.021" svgx:width="0.5,0.33,0.5,0.78,0.44,0.25,0.28,0.5,0.25,0.5,0.44,0.33,0.28,0.5,0.5,0.39,0.25,0.44,0.28,0.28,0.5,0.28,0.44,0.44,0.28,0.25,0.5,0.5,0.44,0.5,0.5,0.28,0.5,0.5,0.44,0.39,0.25,0.5,0.33,0.25,0.89,0.56,0.25,0.44,0.5,0.5,0.25,0.28,0.5,0.25,0.39,0.28,0.5,0.5,0.5,0.25,0.28,0.5,0.44,0.25,0.44,0.5,0.33,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">drome in various clinical phenotypes of MS and to study the cor-</text>
   <text y="642.087" x="62.362,65.359,69.355,71.857,75.853,78.355,80.857,85.357,89.857,93.358,95.608,96.382,100.882,104.878,107.38,113.878,117.874,121.87,126.37,128.62,129.394,132.391,136.387,138.889,141.391,145.891,150.391,154.387,156.637,157.411,161.407,165.907,170.407,172.657,173.431,181.432,186.436,188.686,189.46,193.456,195.958,198.46,202.96,205.462,209.458,213.454,215.956,218.206,218.98,223.48,227.476,230.473,234.469,241.471,245.467,247.969,251.965,254.962,258.463,260.713,261.487,265.483,268.984,271.234,272.008,278.506,282.502,285.004,287.506,289.756,290.53,294.526,298.027" svgx:width="0.33,0.44,0.28,0.44,0.28,0.28,0.5,0.5,0.39,0.25,0.55,0.5,0.44,0.28,0.72,0.44,0.44,0.5,0.25,0.55,0.33,0.44,0.28,0.28,0.5,0.5,0.44,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.89,0.56,0.25,0.55,0.44,0.28,0.28,0.5,0.28,0.44,0.44,0.28,0.25,0.55,0.5,0.44,0.33,0.44,0.78,0.44,0.28,0.44,0.33,0.39,0.25,0.55,0.44,0.39,0.25,0.55,0.72,0.44,0.28,0.28,0.25,0.55,0.44,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">relations between fatique and MS clinical parameters as well as </text>
   <text y="653.085" x="62.362,64.864,71.866,78.868,83.368,87.868,92.368,99.37,103.87,108.37,112.87,115.372,119.368,121.87,124.372,128.872,133.372,135.622,138.124,142.624,146.62,149.617,153.613,158.113,162.028" svgx:width="0.28,0.78,0.78,0.5,0.5,0.5,0.78,0.5,0.5,0.5,0.28,0.44,0.28,0.28,0.5,0.5,0.25,0.28,0.5,0.44,0.33,0.44,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">immunomodulating therapy.</text>
   <text y="664.083" x="62.362,70.858,74.854,77.851,82.855,87.355,92.359,95.86,98.857" svgx:width="0.94,0.44,0.33,0.56,0.5,0.56,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Methods: </text>
   <text y="664.083" x="101.251,109.027,113.023,115.417,119.413,123.913,127.909,134.911,137.413,141.913,145.909,150.409,152.803,157.303,161.803,166.303,168.697,173.197,177.193,179.695,182.197,186.193,190.693,193.195,196.696,199.09,205.588,208.09,210.592,215.092,217.486,221.482,223.984,226.486,230.986,233.488,237.484,241.48,243.982,246.484,250.984,253.378,257.878,261.874,264.871,267.373,271.873,275.869,280.369,282.763,290.764,295.768,298.018" svgx:width="0.94,0.44,0.25,0.44,0.5,0.44,0.78,0.28,0.5,0.44,0.5,0.25,0.5,0.5,0.5,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.72,0.28,0.28,0.5,0.25,0.44,0.28,0.28,0.5,0.28,0.44,0.44,0.28,0.28,0.5,0.25,0.5,0.44,0.33,0.28,0.5,0.44,0.5,0.25,0.89,0.56,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">We examined 106 patients with clinically defined MS, </text>
   <text y="675.081" x="62.362,66.358,70.354,74.35,78.85,81.847,86.347,88.849,93.349,97.849,100.099,101.206,103.708,108.208,110.458,111.565,114.067,118.567,122.563,124.813,125.92,133.921,137.917,144.415,148.915,153.415,157.411,159.913,164.413,166.915,170.416,172.666,173.773,177.769,180.766,183.268,185.77,189.766,192.763,195.265,199.261,201.763,204.013,205.12,209.62,214.12,216.37,217.477,220.474,224.47,231.472,235.468,237.97,241.966,244.468,246.718,247.825,254.827,258.823,262.819,267.319,269.569,270.676,274.672,279.172,283.168,285.67,287.92,289.027,293.527,298.027" svgx:width="0.44,0.44,0.44,0.5,0.33,0.5,0.28,0.5,0.5,0.25,0.55,0.28,0.5,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.89,0.44,0.72,0.5,0.5,0.44,0.28,0.5,0.33,0.39,0.25,0.55,0.44,0.33,0.28,0.28,0.44,0.33,0.28,0.44,0.28,0.25,0.55,0.5,0.5,0.25,0.55,0.33,0.44,0.78,0.44,0.28,0.44,0.28,0.25,0.55,0.78,0.44,0.44,0.5,0.25,0.55,0.44,0.5,0.44,0.28,0.25,0.55,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">according to the McDonald’s criteria; 82 female; mean age: 38 </text>
   <text y="686.079" x="62.362,67.303,71.803,76.303,78.175,82.675,86.671,90.667,93.664,97.165,99.667,101.539,108.541,112.537,116.533,121.033,122.905,127.405,129.907,133.408,137.404,141.4,144.901,148.897,150.769,155.269,159.769,162.766,166.762,169.264,171.766,176.266,180.766,183.268,185.14,189.307,193.807,195.679,200.62,202.492,206.992,209.242,213.742,215.614,220.114,224.11,228.106,231.103,234.604,237.106,238.978,245.98,249.976,253.972,258.472,260.344,265.843,272.341,277.345,282.349,284.851,286.723,291.223,293.473,297.973" svgx:width="0.55,0.5,0.5,0.25,0.5,0.44,0.44,0.33,0.39,0.28,0.25,0.78,0.44,0.44,0.5,0.25,0.5,0.28,0.39,0.44,0.44,0.39,0.44,0.25,0.5,0.5,0.33,0.44,0.28,0.28,0.5,0.5,0.28,0.25,0.5,0.5,0.25,0.55,0.25,0.5,0.25,0.5,0.25,0.5,0.44,0.44,0.33,0.39,0.28,0.25,0.78,0.44,0.44,0.5,0.25,0.61,0.72,0.56,0.56,0.28,0.25,0.5,0.25,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">±10 years; mean disease duration: 11 ± 7.0 years; mean EDSS: 3.0 </text>
   <text y="697.077" x="62.362,67.303,70.21,74.71,76.96,81.46,83.71,86.617,89.614,94.114,97.021,101.521,106.021,108.928,113.428,117.424,119.926,122.428,126.424,130.924,133.426,136.927,139.834,147.835,152.839,155.746,159.742,164.242,168.742,171.739,175.24,179.236,182.143,188.641,192.637,196.138,199.045,202.042,206.038,208.54,212.536,217.036,220.537,223.039,227.539,232.039,235.036,238.033,242.029,249.031,251.533,254.035,256.537,259.039,263.539,268.039,270.289,273.196,275.698,280.198,283.105,287.605,292.105,295.012,298.009" svgx:width="0.55,0.25,0.5,0.25,0.5,0.25,0.25,0.33,0.5,0.25,0.5,0.5,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.89,0.56,0.25,0.44,0.5,0.5,0.33,0.39,0.44,0.25,0.72,0.44,0.39,0.25,0.33,0.44,0.28,0.44,0.5,0.39,0.28,0.5,0.5,0.33,0.33,0.44,0.78,0.28,0.28,0.28,0.28,0.5,0.5,0.25,0.25,0.28,0.5,0.25,0.5,0.5,0.25,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">± 1.5. In 63 patients MS course was relapsing-remitting, in 23 - </text>
   <text y="708.075" x="62.362,66.862,69.859,74.359,78.859,81.856,85.852,89.353,92.854,95.356,99.856,103.852,106.102,107.308,110.305,114.301,116.803,120.799,125.299,128.8,131.302,135.802,140.302,142.552,144.802,146.008,148.51,153.01,155.26,156.466,160.966,165.466,167.716,168.922,171.919,174.169,175.375,178.876,182.872,186.868,191.368,195.868,200.368,204.364,207.361,211.861,214.111,215.317,219.817,222.814,227.314,231.814,234.811,238.807,242.308,245.809,248.311,252.811,256.807,259.057,261.307,262.513,267.517,272.017,275.014,277.516,282.016,285.013,289.513,294.013,298.009" svgx:width="0.5,0.33,0.5,0.5,0.33,0.44,0.39,0.39,0.28,0.5,0.44,0.25,0.55,0.33,0.44,0.28,0.44,0.5,0.39,0.28,0.5,0.5,0.25,0.25,0.55,0.28,0.5,0.25,0.55,0.5,0.5,0.25,0.55,0.33,0.25,0.55,0.39,0.44,0.44,0.5,0.5,0.5,0.44,0.33,0.5,0.25,0.55,0.5,0.33,0.5,0.5,0.33,0.44,0.39,0.39,0.28,0.5,0.44,0.25,0.25,0.55,0.56,0.5,0.33,0.28,0.5,0.33,0.5,0.5,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">progressive relapsing, in 20 - secondary progressive. Forty-one </text>
   <text y="719.073" x="62.362,66.862,70.858,73.36,75.862,79.858,84.358,86.86,90.361,92.242,98.74,102.736,105.733,109.729,111.61,114.112,117.109,121.105,125.101,127.603,131.599,136.099,137.98,144.478,146.98,149.482,153.982,155.863,158.365,162.865,165.367,169.363,172.36,175.357,179.353,182.35,186.85,191.35,193.231,197.731,201.727,204.229,208.225,210.475,212.356,214.858,219.358,223.354,225.235,229.735,232.237,236.737,240.733,243.73,245.611,249.778,254.278,256.159,259.156,261.037,265.537,268.039,272.035,274.537,277.039,280.036,284.032,291.034,295.03,298.027" svgx:width="0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.72,0.44,0.33,0.44,0.25,0.28,0.33,0.44,0.44,0.28,0.44,0.5,0.25,0.72,0.28,0.28,0.5,0.25,0.28,0.5,0.28,0.44,0.33,0.33,0.44,0.33,0.5,0.5,0.25,0.5,0.44,0.28,0.44,0.25,0.25,0.28,0.5,0.44,0.25,0.5,0.28,0.5,0.44,0.33,0.25,0.5,0.5,0.25,0.33,0.25,0.5,0.28,0.44,0.28,0.28,0.33,0.44,0.78,0.44,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">patients were treated with interferon beta, the other 11 - glatiramer </text>
   <text y="730.071" x="62.362,66.358,70.354,74.35,76.852,80.848,83.35,87.346,89.596,91.846,93.304,97.804,102.304,104.554,106.012,109.009,116.011,118.513,121.015,125.515,130.015,134.011,138.511,141.013,144.01,148.51,153.01,157.006,159.256,160.714,164.71,169.21,173.71,175.96,177.418,181.918,184.168,185.626,192.124,194.626,197.128,201.628,203.878,205.336,209.836,213.832,216.334,220.33,222.832,225.334,229.33,233.83,240.832,244.828,249.328,251.578,253.828,254.791,261.289,263.791,266.293,268.543,270.001,274.501,278.497,280.999,283.501,287.497,291.997,294.499,298.0" svgx:width="0.44,0.44,0.44,0.28,0.44,0.28,0.44,0.25,0.25,0.55,0.5,0.5,0.25,0.55,0.33,0.78,0.28,0.28,0.5,0.5,0.44,0.5,0.28,0.33,0.5,0.5,0.44,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.5,0.25,0.55,0.72,0.28,0.28,0.5,0.25,0.55,0.5,0.44,0.28,0.44,0.28,0.28,0.44,0.5,0.78,0.44,0.5,0.25,0.25,0.55,0.72,0.28,0.28,0.25,0.55,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">acetate, 18 -mitoxantrone and 6 with natalizumab. All patients </text>
  </g>
  <path style="fill:none;stroke:rgb(0,0,0);stroke-width:0.44;" d="M310.020 314.300 L357.260 314.300 "/>
  <path style="fill:none;stroke:rgb(0,0,0);stroke-width:0.44;" d="M310.020 709.300 L349.260 709.300 "/>
  <g begin="text">
   <text y="77.103" x="310.016,314.012,318.512,325.514,330.014,332.516,336.512,339.014,343.01,347.51,349.463,353.459,355.412,359.912,364.412,368.408,371.909,374.411,376.913,381.413,385.913,390.413,394.409,396.911,399.908,403.904,405.857,409.853,414.353,418.853,422.354,424.856,428.357,430.859,433.361,437.861,442.361,444.314,448.814,451.811,454.313,456.266,464.267,468.767,473.267,475.769,478.766,481.268,485.264,489.764,491.717,496.721,500.717,503.219,505.721,510.221,514.721,518.717,520.67,523.667,530.669,535.169,539.165,543.161,545.663" svgx:width="0.44,0.5,0.78,0.5,0.28,0.44,0.28,0.44,0.5,0.25,0.44,0.25,0.5,0.5,0.44,0.39,0.28,0.28,0.5,0.5,0.5,0.44,0.28,0.33,0.44,0.25,0.44,0.5,0.5,0.39,0.28,0.39,0.28,0.28,0.5,0.5,0.25,0.5,0.33,0.28,0.25,0.89,0.5,0.5,0.28,0.33,0.28,0.44,0.5,0.25,0.56,0.44,0.28,0.28,0.5,0.5,0.44,0.25,0.33,0.78,0.5,0.44,0.44,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">completed a questionnaire consisting of: Modified Fatigue Impact </text>
   <text y="88.101" x="310.016,315.02,319.016,323.012,325.514,329.51,331.76,333.191,336.188,344.189,349.193,352.19,357.194,360.191,362.441,364.691,366.122,372.125,376.121,380.117,384.617,386.867,388.298,394.796,398.792,403.292,406.289,410.285,413.786,417.287,419.789,424.289,428.789,431.039,432.47,435.467,439.967,444.467,448.463,452.963,455.465,459.965,462.962,467.462,469.712,471.143,474.14,480.143,486.641,489.638,492.635,494.885,496.316,500.312,504.812,509.312,511.562,512.993,518.492,524.99,527.987,532.487,538.985,541.235,542.666,545.663" svgx:width="0.56,0.44,0.44,0.28,0.44,0.25,0.55,0.33,0.89,0.56,0.33,0.56,0.33,0.25,0.25,0.55,0.67,0.44,0.44,0.5,0.25,0.55,0.72,0.44,0.5,0.33,0.44,0.39,0.39,0.28,0.5,0.5,0.25,0.55,0.33,0.5,0.5,0.44,0.5,0.28,0.5,0.33,0.5,0.25,0.55,0.33,0.67,0.72,0.33,0.33,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.61,0.72,0.33,0.5,0.72,0.25,0.55,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Scale (MFIS), Beck Depression Inventory (BDI) and EQ-5D - </text>
   <text y="99.099" x="310.016,313.517,316.019,320.015,324.515,329.015,333.011,336.008,340.508,343.01,346.511,350.507,355.007,357.833,360.335,364.835,368.336,370.838,373.835,378.335,385.337,389.333,393.833,396.335,399.161,402.158,406.658,409.655,412.481,416.981,420.482,424.478,427.304,431.3,434.801,437.627,441.623,444.449,451.451,455.447,459.443,462.944,467.444,470.441,474.437,477.263,481.763,484.76,487.586,492.086,496.082,500.078,502.58,505.082,509.582,512.408,516.908,521.408,523.91,527.906,532.406,539.408,543.404,545.654" svgx:width="0.39,0.28,0.44,0.5,0.5,0.44,0.33,0.5,0.28,0.39,0.44,0.5,0.25,0.28,0.5,0.39,0.28,0.33,0.5,0.78,0.44,0.5,0.28,0.25,0.33,0.5,0.33,0.25,0.5,0.39,0.44,0.25,0.44,0.39,0.25,0.44,0.25,0.78,0.44,0.44,0.39,0.5,0.33,0.44,0.25,0.5,0.33,0.25,0.5,0.44,0.44,0.28,0.28,0.5,0.25,0.5,0.5,0.28,0.44,0.5,0.78,0.44,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">standardised instrument for use as a measure of health outcome. </text>
   <text y="110.097" x="310.016,315.02,319.016,321.518,324.02,328.016,332.516,335.018,338.519,340.769,347.267,349.769,352.271,356.771,359.021,362.522,366.518,371.018,375.014,378.011,382.007,384.257,388.757,392.753,397.253,400.25,404.246,407.747,411.248,413.75,418.25,422.75,425.0,431.498,435.494,438.491,442.487,444.737,448.733,453.233,457.229,459.731,464.231,468.731,472.727,477.227" svgx:width="0.56,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.72,0.28,0.28,0.5,0.25,0.39,0.44,0.5,0.44,0.33,0.44,0.25,0.5,0.44,0.5,0.33,0.44,0.39,0.39,0.28,0.5,0.5,0.25,0.72,0.44,0.33,0.44,0.25,0.44,0.5,0.44,0.28,0.5,0.5,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Patients with severe depression were excluded.</text>
   <text y="121.095" x="310.016,316.514,320.51,324.011,329.015,331.517,334.514,338.015,341.012" svgx:width="0.72,0.44,0.39,0.56,0.28,0.33,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Results: </text>
   <text y="121.095" x="343.091,348.095,352.091,354.593,357.095,361.595,366.095,370.091,372.17,375.671,380.171,384.671,389.171,392.168,396.668,403.67,407.666,409.745,416.243,420.239,423.74,425.819,429.815,434.315,438.815,441.812,444.314,447.311,454.313,458.309,462.809,464.879,467.381,471.881,473.96,478.46,482.96,490.457,492.536,497.036,501.032,503.534,506.036,510.032,514.532,517.034,520.535,522.785,524.702,530.201,534.701,538.697,541.694,545.69" svgx:width="0.56,0.44,0.28,0.28,0.5,0.5,0.44,0.25,0.39,0.5,0.5,0.5,0.33,0.5,0.78,0.44,0.25,0.72,0.44,0.39,0.25,0.44,0.5,0.5,0.33,0.28,0.33,0.78,0.44,0.5,0.25,0.28,0.5,0.25,0.5,0.5,0.83,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.25,0.61,0.5,0.44,0.33,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Fatigue syndrome was confirmed in 96% patients. There </text>
   <text y="132.093" x="310.016,316.514,320.51,324.011,326.261,328.115,332.615,337.115,339.365,341.219,345.215,349.715,352.712,355.709,359.705,362.207,366.203,368.705,371.207,375.707,380.207,382.457,384.311,388.811,392.807,395.309,401.807,405.803,409.799,414.299,416.549,418.403,421.4,425.396,427.898,430.4,434.9,439.4,443.396,445.646,447.5,451.496,455.996,460.496,462.746,464.6,467.597,472.097,474.599,477.101,481.601,488.099,490.601,495.101,499.601,501.851,503.705,508.205,512.201,515.198,519.194,526.196,530.192,532.694,536.69,539.687,543.188,545.69" svgx:width="0.72,0.44,0.39,0.25,0.55,0.5,0.5,0.25,0.55,0.44,0.5,0.33,0.33,0.44,0.28,0.44,0.28,0.28,0.5,0.5,0.25,0.55,0.5,0.44,0.28,0.72,0.44,0.44,0.5,0.25,0.55,0.33,0.44,0.28,0.28,0.5,0.5,0.44,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.33,0.5,0.28,0.28,0.5,0.72,0.28,0.5,0.5,0.25,0.55,0.5,0.44,0.33,0.44,0.78,0.44,0.28,0.44,0.33,0.39,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">was no correlation between fatigue and following parameters: </text>
   <text y="143.091" x="310.016,314.516,318.512,321.014,323.516,327.512,332.012,334.514,336.764,337.547,341.543,346.043,350.039,352.289,354.539,355.322,359.822,363.818,368.318,372.818,376.814,379.451,381.701,383.951,384.734,389.234,393.734,400.736,405.236,409.232,412.229,414.479,415.262,419.762,422.759,425.009,425.792,428.789,432.785,435.287,439.283,443.783,447.284,451.28,454.781,457.031,457.814,461.81,466.31,470.81,473.06,473.843,481.844,486.848,489.098,489.881,493.877,498.377,502.877,505.874,509.375,513.371,515.621,517.871,518.654,523.658,527.654,530.156,532.658,537.158,541.658,545.654" svgx:width="0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.25,0.55,0.44,0.5,0.44,0.25,0.25,0.55,0.5,0.44,0.5,0.5,0.44,0.33,0.25,0.25,0.55,0.5,0.5,0.78,0.5,0.44,0.33,0.25,0.55,0.5,0.33,0.25,0.55,0.33,0.44,0.28,0.44,0.5,0.39,0.44,0.39,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.89,0.56,0.25,0.55,0.44,0.5,0.5,0.33,0.39,0.44,0.25,0.25,0.55,0.56,0.44,0.28,0.28,0.5,0.5,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">patient age, gender, number of relapses and MS course. Fatigue </text>
   <text y="154.089" x="310.016,316.514,320.51,324.011,326.261,327.116,330.617,333.119,337.619,342.119,344.621,347.618,350.12,354.116,358.112,362.612,365.114,367.616,372.116,374.366,375.221,379.217,382.718,386.219,390.719,394.715,397.217,401.213,403.715,407.711,412.211,414.461,415.316,421.814,424.316,426.818,431.318,433.568,434.423,438.923,442.919,447.419,450.416,454.412,457.913,461.414,463.916,468.416,472.916,475.166,476.021,479.018,484.022,489.098,491.348,492.203,496.703,498.953,503.453,507.953,510.95,513.2,514.055,518.051,522.551,527.051,529.301,530.156,534.656,538.652,541.154,545.654" svgx:width="0.72,0.44,0.39,0.25,0.55,0.39,0.28,0.5,0.5,0.28,0.33,0.28,0.44,0.44,0.5,0.28,0.28,0.5,0.25,0.55,0.44,0.39,0.39,0.5,0.44,0.28,0.44,0.28,0.44,0.5,0.25,0.55,0.72,0.28,0.28,0.5,0.25,0.55,0.5,0.44,0.5,0.33,0.44,0.39,0.39,0.28,0.5,0.5,0.25,0.55,0.33,0.56,0.56,0.25,0.55,0.5,0.25,0.5,0.5,0.33,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.5,0.44,0.28,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">was significantly associated with depression (P&lt; 0.01) and pain </text>
   <text y="165.087" x="310.016,313.517,317.513,322.013,326.009,329.006,331.508,334.01,338.51,340.823,343.82,348.824,353.9,356.213,360.713,362.963,367.463,371.963,374.96,377.21,379.361,387.137,391.133,393.446,396.443,400.943,405.443,409.943,414.443,416.756,420.752,423.065,426.566,429.068,433.064,435.566,438.068,441.569,444.071,446.573,450.569,454.565,457.067,459.569,464.069,466.382,469.883,472.385,476.885,481.385,483.887,486.884,489.386,493.382,497.378,501.878,504.38,506.693,510.689,515.189,518.186,521.183,525.179,527.681,531.677,534.179,536.681,541.181,545.681" svgx:width="0.39,0.44,0.5,0.44,0.33,0.28,0.28,0.5,0.25,0.33,0.56,0.56,0.25,0.5,0.25,0.5,0.5,0.33,0.25,0.25,0.94,0.44,0.25,0.33,0.5,0.5,0.5,0.5,0.25,0.44,0.25,0.39,0.28,0.44,0.28,0.28,0.39,0.28,0.28,0.44,0.44,0.28,0.28,0.5,0.25,0.39,0.28,0.5,0.5,0.28,0.33,0.28,0.44,0.44,0.5,0.28,0.25,0.44,0.5,0.33,0.33,0.44,0.28,0.44,0.28,0.28,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">severity (P&lt; 0.01). We found a statistically significant correlation </text>
   <text y="176.085" x="310.016,314.516,318.512,321.014,327.512,331.508,335.504,340.004,342.254,342.974,345.971,349.967,352.469,354.971,359.471,363.971,367.967,370.217,370.937,374.933,379.433,383.933,386.183,386.912,394.913,399.917,402.167,402.887,407.387,411.887,414.884,418.88,421.382,423.884,428.384,432.884,435.134,435.854,438.851,443.855,448.931,453.431,455.681,460.181,464.681,467.678,469.928,472.745,478.244,482.744,486.74,488.99,489.71,493.211,495.713,500.213,504.713,509.213,511.463,512.192,516.188,518.69,522.191,526.691,528.941,529.661,533.657,538.157,542.657" svgx:width="0.5,0.44,0.28,0.72,0.44,0.44,0.5,0.25,0.55,0.33,0.44,0.28,0.28,0.5,0.5,0.44,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.89,0.56,0.25,0.55,0.5,0.5,0.33,0.44,0.28,0.28,0.5,0.5,0.25,0.55,0.33,0.56,0.56,0.5,0.25,0.5,0.5,0.33,0.25,0.25,0.61,0.5,0.44,0.25,0.55,0.39,0.28,0.5,0.5,0.5,0.25,0.55,0.44,0.28,0.39,0.5,0.25,0.55,0.44,0.5,0.5,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">between fatigue and MS duration (P=0.03). The study also con-</text>
   <text y="187.083" x="310.016,313.013,315.515,318.512,325.514,329.51,334.01,336.611,339.113,343.613,347.609,350.21,354.71,358.706,363.206,367.202,370.199,372.701,376.697,379.199,383.195,385.697,388.298,390.8,397.802,402.302,406.298,410.294,412.796,415.397,419.897,422.894,425.495,427.997,432.497,436.493,439.094,441.596,448.598,455.6,460.1,464.6,469.1,476.102,480.602,485.102,489.602,492.104,496.1,498.602,503.102,506.099,510.599,513.2,515.702,520.202,524.198,527.195,531.191,535.691,538.193,542.189,545.69" svgx:width="0.33,0.28,0.33,0.78,0.44,0.5,0.25,0.28,0.5,0.44,0.25,0.5,0.44,0.5,0.44,0.33,0.28,0.44,0.28,0.44,0.28,0.25,0.28,0.78,0.5,0.44,0.44,0.28,0.25,0.5,0.33,0.25,0.28,0.5,0.44,0.25,0.28,0.78,0.78,0.5,0.5,0.5,0.78,0.5,0.5,0.5,0.28,0.44,0.28,0.5,0.33,0.5,0.25,0.28,0.5,0.44,0.33,0.44,0.5,0.28,0.44,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">firmed the beneficial impact of the immunomodulatory therapies </text>
   <text y="198.081" x="310.016,314.516,319.016,321.266,324.263,328.259,330.761,333.263,337.763,342.263,346.259,348.509,352.01,356.51,361.01,365.51,368.507,373.007,380.009,384.005,386.255,389.252,394.256,399.332,401.582,406.082,408.332,412.832,417.332,420.329" svgx:width="0.5,0.5,0.25,0.33,0.44,0.28,0.28,0.5,0.5,0.44,0.25,0.39,0.5,0.5,0.5,0.33,0.5,0.78,0.44,0.25,0.33,0.56,0.56,0.25,0.5,0.25,0.5,0.5,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">on fatigue syndrome (P&lt; 0.01).</text>
   <text y="209.079" x="310.016,316.514,321.014,326.018,330.014,332.516,337.52,341.021,343.523,348.023,353.027,356.528,359.525" svgx:width="0.72,0.5,0.56,0.44,0.28,0.56,0.39,0.28,0.5,0.56,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Conclusions: </text>
   <text y="209.079" x="361.901,366.905,370.901,373.403,375.905,380.405,384.905,388.901,391.277,393.779,397.28,399.656,404.156,408.152,411.149,415.649,418.025,421.022,424.019,428.015,432.515,437.015,441.011,445.511,448.013,450.389,458.39,463.394,465.77,469.271,473.771,480.773,485.273,487.775,492.275,499.277,501.653,504.155,508.655,513.155,517.151,521.651,525.647,530.147,534.647,538.643,543.143,545.645" svgx:width="0.56,0.44,0.28,0.28,0.5,0.5,0.44,0.25,0.28,0.39,0.25,0.5,0.44,0.33,0.5,0.25,0.33,0.33,0.44,0.5,0.5,0.44,0.5,0.28,0.25,0.89,0.56,0.25,0.39,0.5,0.78,0.5,0.28,0.5,0.78,0.25,0.28,0.5,0.5,0.44,0.5,0.44,0.5,0.5,0.44,0.5,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Fatigue is very frequent MS symptom independent </text>
   <text y="220.077" x="310.016,314.516,317.513,319.763,321.005,323.507,328.007,332.003,334.253,335.495,337.997,341.993,346.493,350.489,352.991,355.241,356.483,360.983,363.98,366.23,367.472,371.972,374.474,377.975,381.971,386.471,388.973,391.475,393.977,396.479,400.979,403.229,404.471,408.971,411.968,414.218,415.46,419.456,421.958,424.46,428.96,431.462,435.458,439.454,441.956,444.206,445.448,449.948,452.45,455.951,459.947,463.943,467.444,471.44,473.69,474.932,478.433,482.933,487.433,489.935,494.435,498.935,502.931,505.181,507.431,508.673,515.171,519.671,522.668,524.918,526.16,529.661,532.163,536.663,541.163,545.663" svgx:width="0.5,0.33,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.28,0.44,0.5,0.44,0.28,0.25,0.55,0.5,0.33,0.25,0.55,0.5,0.28,0.39,0.44,0.5,0.28,0.28,0.28,0.28,0.5,0.25,0.55,0.5,0.33,0.25,0.55,0.44,0.28,0.28,0.5,0.28,0.44,0.44,0.28,0.25,0.55,0.5,0.28,0.39,0.44,0.44,0.39,0.44,0.25,0.55,0.39,0.5,0.5,0.28,0.5,0.5,0.44,0.25,0.25,0.55,0.72,0.5,0.33,0.25,0.55,0.39,0.28,0.5,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">of the level of disability or clinical disease subtype. Our study </text>
   <text y="231.075" x="310.016,313.517,318.017,322.517,329.015,332.516,334.757,337.259,341.759,345.755,348.257,350.498,353.0,357.5,361.496,363.737,366.239,373.241,380.243,384.743,389.243,393.743,400.745,405.245,409.745,414.245,416.747,420.743,423.245,427.745,430.742,435.242,437.483,439.985,442.982,446.978,450.974,453.476,460.478,464.474,468.974,471.476,473.717,477.713,481.709,486.209,488.45,490.952,497.954,502.454,505.451,509.951,514.451,518.447,520.688,523.685,527.681,530.183,532.685,537.185,541.685,545.681" svgx:width="0.39,0.5,0.5,0.72,0.39,0.25,0.28,0.5,0.44,0.28,0.25,0.28,0.5,0.44,0.25,0.28,0.78,0.78,0.5,0.5,0.5,0.78,0.5,0.5,0.5,0.28,0.44,0.28,0.5,0.33,0.5,0.25,0.28,0.33,0.44,0.44,0.28,0.78,0.44,0.5,0.28,0.25,0.44,0.44,0.5,0.25,0.28,0.78,0.5,0.33,0.5,0.5,0.44,0.25,0.33,0.44,0.28,0.28,0.5,0.5,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">shows that the immunomodulatory treatment can improve fatigue </text>
   <text y="242.073" x="310.016,312.518,317.018,319.268,327.269,332.273,334.523,339.023,343.019,345.521,348.023,352.019,356.519,359.021,362.522" svgx:width="0.28,0.5,0.25,0.89,0.56,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">in MS patients.</text>
   <text y="269.073" x="310.016,315.515,320.015,324.515" svgx:width="0.61,0.5,0.5,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">P944</text>
   <text y="280.071" x="310.016,316.514,321.518,326.018,331.022,335.522,338.519,343.523,346.025,348.527,353.531,358.535,366.032,369.029,373.529,378.029,380.531,385.535,387.785,392.285,394.535,397.532,402.032,406.028,408.278,413.282,417.278,420.275,424.271,429.275,432.776,437.276,441.272,443.522,448.022,452.522,456.518,460.514,465.014,469.01,472.007,474.509,479.009,481.511,484.508,489.008,491.258,493.76,498.764" svgx:width="0.72,0.56,0.5,0.56,0.5,0.33,0.56,0.28,0.28,0.56,0.56,0.83,0.33,0.5,0.5,0.28,0.56,0.25,0.5,0.25,0.33,0.5,0.44,0.25,0.56,0.44,0.33,0.44,0.56,0.39,0.5,0.44,0.25,0.5,0.5,0.44,0.44,0.5,0.44,0.33,0.28,0.5,0.28,0.33,0.5,0.25,0.28,0.56,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Abobotulinumtoxin a for detrusor overactivity in </text>
   <text y="291.069" x="310.016,315.02,319.52,322.517,325.019,329.015,334.019,337.016,340.517,342.767,349.265,351.767,354.764,359.768,362.018,369.515,374.519,377.021,380.018,382.52,387.524,390.026,394.022,396.272,399.773,403.769,406.271,410.267,414.263,418.763,422.264,424.766,428.267,431.264,433.514,437.51,440.507,443.504,447.5,451.496,454.493,456.743,461.243,466.247,468.497,473.501,478.505,483.005,485.507,488.009,491.006,495.506,497.756,502.256,505.253,507.503,510.005,512.507,515.504,519.5" svgx:width="0.56,0.5,0.33,0.28,0.44,0.56,0.33,0.39,0.25,0.72,0.28,0.33,0.56,0.25,0.83,0.56,0.28,0.33,0.28,0.56,0.28,0.44,0.25,0.39,0.44,0.28,0.44,0.44,0.5,0.39,0.28,0.39,0.33,0.25,0.44,0.33,0.33,0.44,0.44,0.33,0.25,0.5,0.56,0.25,0.56,0.56,0.5,0.28,0.28,0.33,0.5,0.25,0.5,0.33,0.25,0.28,0.28,0.33,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">patients with multiple sclerosis: effect on quality of life </text>
   <text y="302.067" x="310.016,314.516,319.52,324.524,326.774,331.778,335.774,340.274,345.278,349.778,354.782,359.282,366.779,369.281,373.277,375.527,380.531,385.031,389.027,393.527,401.024,405.02,408.017,412.013,416.009" svgx:width="0.5,0.56,0.56,0.25,0.56,0.44,0.5,0.56,0.5,0.56,0.5,0.83,0.28,0.44,0.25,0.56,0.5,0.44,0.5,0.83,0.44,0.33,0.44,0.44,0.39" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">and urodynamic parameters</text>
   <text y="313.065" x="310.016,316.019,322.517,326.018,328.268,336.269,340.769,343.766,347.762,350.264,353.261" svgx:width="0.67,0.72,0.39,0.25,0.89,0.5,0.33,0.44,0.28,0.33,0.44" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">RDJ Moreira</text>
   <text y="310.583" x="357.256" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="313.103" x="360.181,362.431,364.681,371.179,376.183,381.187,383.437,389.935,394.435,398.935" svgx:width="0.25,0.25,0.72,0.56,0.56,0.25,0.72,0.5,0.5,0.44" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, APF Auge</text>
   <text y="310.583" x="402.931" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="313.103" x="405.856,408.106,410.356,416.854,422.857,425.107,430.606,435.106,437.608,440.11,444.106" svgx:width="0.25,0.25,0.72,0.67,0.25,0.61,0.5,0.28,0.28,0.44,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, VB Toller</text>
   <text y="310.583" x="447.102" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="313.103" x="450.027,452.277,454.527,460.026,466.524,468.774,474.777,478.773,481.77,485.766,490.266,494.262,496.764,499.266" svgx:width="0.25,0.25,0.61,0.72,0.25,0.67,0.44,0.33,0.44,0.5,0.44,0.28,0.28,0.44" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, EG Carabetta</text>
   <text y="310.583" x="503.261" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="313.103" x="506.186,508.436,510.686,517.184,522.188,524.438,528.938,533.438" svgx:width="0.25,0.25,0.72,0.56,0.25,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, GS do </text>
   <text y="324.101" x="310.013,316.511,319.013,321.515,326.015,330.011" svgx:width="0.72,0.28,0.28,0.5,0.44,0.28" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Olival</text>
   <text y="321.583" x="332.516" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="324.103" x="335.44,337.69,339.94,345.943,350.947,353.197,358.696,361.198,363.701,368.201,372.197,375.194" svgx:width="0.25,0.25,0.67,0.56,0.25,0.61,0.28,0.28,0.5,0.44,0.33,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, CP Tilbery</text>
   <text y="321.583" x="379.693" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="324.103" x="382.618,384.868,387.118,392.617,399.115,401.365,406.864,411.364,413.866,417.862,422.362" svgx:width="0.25,0.25,0.61,0.72,0.25,0.61,0.5,0.28,0.44,0.5,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, LG Toledo</text>
   <text y="321.583" x="426.862" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="332.581" x="310.014" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:5.85px;stroke:none;">1</text>
   <text y="335.103" x="312.941,318.44,322.94,326.936,331.436,333.938,338.438,342.938,347.438,351.434,353.684,358.184,362.18,364.43,370.433,372.935,376.931,381.431,385.427,387.929,392.429,395.93,398.18,405.677,409.673,414.173,416.675,420.671,425.171,428.672,430.922,435.422,439.922,442.172,446.672,451.172,455.672,458.174,462.674,464.924,470.927,475.427,478.928,483.428,485.678,490.178,494.174,496.424,500.924,505.424,509.924,512.174,517.673,522.173,526.673,529.175,533.675,535.925" svgx:width="0.61,0.5,0.44,0.5,0.28,0.5,0.5,0.5,0.44,0.25,0.5,0.44,0.25,0.67,0.28,0.44,0.5,0.44,0.28,0.5,0.39,0.25,0.83,0.44,0.5,0.28,0.44,0.5,0.39,0.25,0.5,0.5,0.25,0.5,0.5,0.5,0.28,0.5,0.25,0.67,0.5,0.39,0.5,0.25,0.5,0.44,0.25,0.5,0.5,0.5,0.25,0.61,0.5,0.5,0.28,0.5,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Faculdade de Ciencias Médicas da Santa Casa de São Paulo, </text>
   <text y="346.101" x="310.016,314.516,319.016,323.516,325.766,331.265,335.765,340.265,342.767,347.267,349.517,351.767,357.266,360.767,365.267,368.768,371.27" svgx:width="0.5,0.5,0.5,0.25,0.61,0.5,0.5,0.28,0.5,0.25,0.25,0.61,0.39,0.5,0.39,0.28,0.28" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">São Paulo, Brazil</text>
   <text y="373.101" x="310.016,316.019,320.519,324.515,329.519,334.019,337.853,342.353,347.357,352.361,357.365,360.362" svgx:width="0.67,0.5,0.44,0.56,0.5,0.44,0.5,0.56,0.56,0.56,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Background: </text>
   <text y="373.101" x="363.836,370.334,374.33,378.83,381.827,386.327,390.827,394.823,399.323,401.825,405.821,408.071,409.295,413.795,417.791,420.293,423.29,427.79,431.291,435.791,438.788,441.038,442.262,446.762,451.262,455.258,458.255,462.251,466.247,468.749,471.251,475.751,478.253,480.755,485.255,487.505,488.729,491.726,498.224,504.722,511.22,514.217,516.467,517.691,520.193,523.694,525.944,527.168,531.164,535.664,542.666" svgx:width="0.72,0.44,0.5,0.33,0.5,0.5,0.44,0.5,0.28,0.44,0.25,0.55,0.5,0.44,0.28,0.33,0.5,0.39,0.5,0.33,0.25,0.55,0.5,0.5,0.44,0.33,0.44,0.44,0.28,0.28,0.5,0.28,0.28,0.5,0.25,0.55,0.33,0.72,0.72,0.72,0.33,0.25,0.55,0.28,0.39,0.25,0.55,0.44,0.5,0.78,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Neurogenic detrusor overactivity (NDO) is com-</text>
   <text y="384.099" x="310.016,317.018,321.518,326.018,328.268,330.068,332.57,337.07,339.32,341.12,345.62,349.616,352.118,354.62,358.616,363.116,365.618,369.119,371.369,373.169,379.667,384.167,388.667,390.917,392.717,396.218,400.718,403.553,406.55,410.546,413.543,415.793,417.593,420.59,423.587,428.087,435.089,437.339,439.139,446.141,450.641,453.143,455.645,458.147,462.647,465.149,469.145,471.395,473.195,476.696,480.692,483.194,487.19,490.187,494.687,498.188,500.69,504.191,506.441,508.241,511.238,519.239,524.738,527.735,529.985,532.235,533.873,541.649,545.645" svgx:width="0.78,0.5,0.5,0.25,0.55,0.28,0.5,0.25,0.55,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.55,0.72,0.5,0.5,0.25,0.55,0.39,0.5,0.33,0.33,0.44,0.33,0.25,0.55,0.33,0.33,0.5,0.78,0.25,0.55,0.78,0.5,0.28,0.28,0.28,0.5,0.28,0.44,0.25,0.55,0.39,0.44,0.28,0.44,0.33,0.5,0.39,0.28,0.39,0.25,0.55,0.33,0.89,0.61,0.33,0.25,0.25,0.55,0.94,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">mon in patients who suffer from multiple sclerosis (ME). We </text>
   <text y="395.097" x="310.016,314.012,317.513,321.014,325.01,328.511,332.012,336.008,340.508,343.091,345.593,350.093,354.089,356.672,360.668,363.503,366.5,369.002,372.998,376.994,380.99,384.905,387.155,389.738,393.239,397.235,400.232,404.228,406.73,411.23,413.813,417.809,422.309,426.809,429.392,433.388,436.223,439.22,443.216,447.212,449.714,453.215,455.798,460.298,464.798,467.381,471.881,476.381,480.377,482.879,485.381,487.883,492.383,494.966,499.466,502.463,505.046,507.548,510.05,513.047,517.043,519.626,524.126,527.123,529.706,533.702,538.202,542.702" svgx:width="0.44,0.39,0.39,0.44,0.39,0.39,0.44,0.5,0.25,0.28,0.5,0.44,0.25,0.44,0.33,0.33,0.28,0.44,0.44,0.44,0.5,0.25,0.25,0.39,0.44,0.33,0.44,0.28,0.5,0.25,0.44,0.5,0.5,0.25,0.44,0.33,0.33,0.44,0.44,0.28,0.39,0.25,0.5,0.5,0.25,0.5,0.5,0.44,0.28,0.28,0.28,0.5,0.25,0.5,0.33,0.25,0.28,0.28,0.33,0.44,0.25,0.5,0.33,0.25,0.44,0.5,0.5,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">assessed the efficacy, safety and effects on quality of life of abo-</text>
   <text y="406.095" x="310.016,314.516,319.016,321.518,326.018,328.52,331.022,335.522,340.022,347.024,349.526,354.026,358.526,361.028,365.528,371.531,374.411,377.408,383.906,389.909,396.407,399.404,405.902,408.899,411.779,414.281,418.781,421.661,426.161,430.157,432.659,435.161,439.157,443.657,446.159,449.66,452.54,459.038,461.54,464.042,468.542,471.422,477.92,484.418,490.916,493.796,496.793,500.789,504.29,508.79,511.292,513.794,516.296,520.796,525.296,528.176,531.173,534.17,538.67,545.672" svgx:width="0.5,0.5,0.28,0.5,0.28,0.28,0.5,0.5,0.78,0.28,0.5,0.5,0.28,0.5,0.72,0.25,0.33,0.72,0.67,0.72,0.33,0.72,0.33,0.25,0.28,0.5,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.72,0.28,0.28,0.5,0.25,0.72,0.72,0.72,0.25,0.33,0.44,0.39,0.5,0.28,0.28,0.28,0.5,0.5,0.25,0.33,0.33,0.5,0.78,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">botulinumtoxinA (ABX-A) in patients with NDO resulting from </text>
   <text y="417.093" x="310.016,317.018,321.518,324.02,326.522,329.024,333.524,336.026,340.022,342.272,345.773,349.769,352.271,356.267,359.264,363.764,367.265,369.767,373.268" svgx:width="0.78,0.5,0.28,0.28,0.28,0.5,0.28,0.44,0.25,0.39,0.44,0.28,0.44,0.33,0.5,0.39,0.28,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">multiple sclerosis.</text>
   <text y="428.091" x="310.016,317.018,322.022,325.019,329.015,333.011,336.008,338.51,343.01,347.006,350.507,353.504" svgx:width="0.78,0.56,0.33,0.44,0.44,0.33,0.28,0.5,0.44,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Objectives: </text>
   <text y="428.091" x="356.438,362.936,366.437,369.938,373.934,377.435,380.936,383.186,383.87,386.372,390.872,394.868,397.118,397.802,401.798,404.633,407.63,410.132,414.128,418.124,422.12,426.035,428.285,430.535,431.219,434.72,438.716,441.713,445.709,448.211,452.711,454.961,455.645,459.641,464.141,468.641,470.891,471.575,475.571,478.406,481.403,485.399,489.395,491.897,495.398,497.648,498.332,502.832,507.332,509.582,510.266,514.766,519.266,523.262,525.764,528.266,530.768,535.268,537.518,538.202,542.702,545.699" svgx:width="0.72,0.39,0.39,0.44,0.39,0.39,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.44,0.33,0.33,0.28,0.44,0.44,0.44,0.5,0.25,0.25,0.55,0.39,0.44,0.33,0.44,0.28,0.5,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.44,0.33,0.33,0.44,0.44,0.28,0.39,0.25,0.55,0.5,0.5,0.25,0.55,0.5,0.5,0.44,0.28,0.28,0.28,0.5,0.25,0.55,0.5,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Assess the efficacy, safety and effects on quality of </text>
   <text y="439.089" x="310.016,312.518,315.02,318.017,322.013,324.263,327.251,331.751,334.748,336.998,339.986,343.982,348.482,352.982,357.482,361.982,364.484,368.984,371.486,373.988,378.488,382.988,389.99,392.492,396.992,401.492,403.994,408.494,414.497,416.747,419.735,422.732,429.23,435.233,441.731,444.728,451.226,454.223,456.473,459.461,461.963,466.463,468.713,471.701,476.201,480.197,482.699,485.201,489.197,493.697,496.199,499.7,501.95,504.938,511.436,513.938,516.44,520.94,523.19,526.178,532.676,539.174,545.672" svgx:width="0.28,0.28,0.33,0.44,0.25,0.55,0.5,0.33,0.25,0.55,0.44,0.5,0.5,0.5,0.5,0.28,0.5,0.28,0.28,0.5,0.5,0.78,0.28,0.5,0.5,0.28,0.5,0.72,0.25,0.55,0.33,0.72,0.67,0.72,0.33,0.72,0.33,0.25,0.55,0.28,0.5,0.25,0.55,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.55,0.72,0.28,0.28,0.5,0.25,0.55,0.72,0.72,0.72,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">life of abobotulinumtoxinA (ABX-A) in patients with NDO </text>
   <text y="450.087" x="310.016,313.013,317.009,320.51,325.01,327.512,330.014,332.516,337.016,341.516,343.766,346.763,349.76,354.26,361.262,363.512,370.514,375.014,377.516,380.018,382.52,387.02,389.522,393.518,395.768,399.269,403.265,405.767,409.763,412.76,417.26,420.761,423.263,426.764" svgx:width="0.33,0.44,0.39,0.5,0.28,0.28,0.28,0.5,0.5,0.25,0.33,0.33,0.5,0.78,0.25,0.78,0.5,0.28,0.28,0.28,0.5,0.28,0.44,0.25,0.39,0.44,0.28,0.44,0.33,0.5,0.39,0.28,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">resulting from multiple sclerosis.</text>
   <text y="461.085" x="310.016,318.422,322.328,325.235,330.149,334.559,339.473,342.884,345.791" svgx:width="0.94,0.44,0.33,0.56,0.5,0.56,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Methods: </text>
   <text y="461.085" x="348.779,353.558,359.966,363.872,366.284,370.694,374.6,376.85,377.588,381.998,385.904,388.316,390.728,394.634,399.044,401.456,404.867,407.117,407.855,414.263,416.675,419.087,423.497,425.747,426.485,434.396,439.31,441.56,442.298,446.708,451.118,455.528,459.434,462.341,468.749,472.655,477.065,479.477,481.727,482.465,484.877,489.287,493.193,495.605,498.512,500.762,501.5,504.407,506.819,509.726,513.137,515.549,518.042,524.45,530.363,536.771,539.678,545.681" svgx:width="0.61,0.72,0.44,0.28,0.5,0.44,0.25,0.55,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.55,0.72,0.28,0.28,0.5,0.25,0.55,0.89,0.56,0.25,0.55,0.5,0.5,0.5,0.44,0.33,0.72,0.44,0.5,0.28,0.25,0.55,0.28,0.5,0.44,0.28,0.33,0.25,0.55,0.33,0.28,0.33,0.39,0.28,0.25,0.72,0.67,0.72,0.33,0.72,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Twelve patients with MS underwent their first ABX-A </text>
   <text y="472.083" x="310.016,312.428,316.838,319.25,323.156,327.062,329.474,331.886,336.296,340.706,342.956,344.126,347.033,351.443,354.35,356.6,357.77,360.677,364.583,367.49,370.397,374.303,378.209,380.621,385.031,387.938,392.348,394.598,395.768,402.176,408.584,414.992,417.152,419.402,420.41,425.819,430.229,434.135,438.545,440.795,441.965,446.375,450.281,454.691,456.941,458.111,462.017,464.429,466.841,471.251,473.663,477.569,481.475,483.887,486.137,487.307,491.213,495.623,500.033,502.283,503.453,507.863,510.77,515.18,519.59,524.0,528.41,532.316,539.228,541.64,545.636" svgx:width="0.28,0.5,0.28,0.44,0.44,0.28,0.28,0.5,0.5,0.25,0.55,0.33,0.5,0.33,0.25,0.55,0.33,0.44,0.33,0.33,0.44,0.44,0.28,0.5,0.33,0.5,0.25,0.55,0.72,0.72,0.72,0.25,0.25,0.55,0.61,0.5,0.44,0.5,0.25,0.55,0.5,0.44,0.5,0.25,0.55,0.44,0.28,0.28,0.5,0.28,0.44,0.44,0.28,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.5,0.33,0.5,0.5,0.5,0.5,0.44,0.78,0.28,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">injection for refractory NDO. They had clinical and urodynamic </text>
   <text y="483.081" x="310.016,313.922,318.332,321.743,324.155,328.565,335.477,339.383,341.795,344.702,349.112,351.245,355.151,358.562,361.973,365.879,369.29,372.701,379.613,383.519,387.929,390.341,392.474,396.884,400.79,403.697,408.107,411.014,414.92,417.053,420.959,425.369,429.779,431.912,434.324,438.734,441.641,445.547,449.453,451.586,458.498,462.908,467.318,469.73,474.14,477.551,479.684,483.59,486.497,488.909,492.815,495.722,497.855,500.267,504.677,507.089,510.995,514.901,517.313,519.725,524.135,528.545,530.705,532.838,536.744,541.154,545.654" svgx:width="0.44,0.5,0.39,0.28,0.5,0.78,0.44,0.28,0.33,0.5,0.25,0.44,0.39,0.39,0.44,0.39,0.39,0.78,0.44,0.5,0.28,0.25,0.5,0.44,0.33,0.5,0.33,0.44,0.25,0.44,0.5,0.5,0.25,0.28,0.5,0.33,0.44,0.44,0.25,0.78,0.5,0.5,0.28,0.5,0.39,0.25,0.44,0.33,0.28,0.44,0.33,0.25,0.28,0.5,0.28,0.44,0.44,0.28,0.28,0.5,0.5,0.25,0.25,0.44,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">cystometry assessment before and three months after injection. and </text>
   <text y="494.079" x="310.016,312.923,317.333,321.239,325.649,330.059,332.471,334.883,339.293,343.199,347.609,351.515,355.421,357.131,363.539,367.949,371.855,374.267,376.679,379.091,383.501,385.211,389.621,392.528,394.247,396.659,399.071,401.978,405.884,407.603,410.015,414.425,416.837,420.743,423.155,424.874,429.788,433.694,438.104,441.011,444.917,446.627,453.035,456.941,459.848,463.754,465.464,469.37,473.78,477.686,480.098,484.508,488.414,490.826,494.732,499.142,501.302,502.859,508.268,512.678,516.584,518.303,522.713,526.619,529.031,531.443,535.349,539.759,542.171,545.672" svgx:width="0.33,0.5,0.44,0.5,0.5,0.28,0.28,0.5,0.44,0.5,0.44,0.44,0.25,0.72,0.5,0.44,0.28,0.28,0.28,0.5,0.25,0.5,0.33,0.25,0.28,0.28,0.33,0.44,0.25,0.28,0.5,0.28,0.44,0.28,0.25,0.56,0.44,0.5,0.33,0.44,0.25,0.72,0.44,0.33,0.44,0.25,0.44,0.5,0.44,0.28,0.5,0.44,0.28,0.44,0.5,0.25,0.25,0.61,0.5,0.44,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Incontinence Quality of life total Score were evaluated. The patients </text>
   <text y="505.077" x="310.016,316.424,320.33,323.237,327.143,329.852,334.262,336.674,341.084,343.496,347.906,351.812,356.222,358.931,361.343,365.753,368.462,370.874,375.284,378.191,382.097,386.003,388.712,393.122,396.029,400.439,404.849,409.259,412.67,415.379,419.285,423.191,427.097,431.507,434.414,438.824,441.236,445.646,450.056,452.765,455.177,459.587,462.296,464.708,467.615,471.521,475.427,477.839,484.751,488.657,493.067,495.479,498.188,502.094,504.839,507.746,510.158,514.064,517.97,521.876,526.286,528.698,531.407,536.321,540.731,543.143,545.645" svgx:width="0.72,0.44,0.33,0.44,0.25,0.5,0.28,0.5,0.28,0.5,0.44,0.5,0.25,0.28,0.5,0.25,0.28,0.5,0.33,0.44,0.44,0.25,0.5,0.33,0.5,0.5,0.5,0.39,0.25,0.44,0.44,0.44,0.5,0.33,0.5,0.28,0.5,0.5,0.25,0.28,0.5,0.25,0.28,0.33,0.44,0.44,0.28,0.78,0.44,0.5,0.28,0.25,0.44,0.33,0.33,0.28,0.44,0.44,0.44,0.5,0.28,0.25,0.56,0.5,0.28,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">were divided in three groups according to treatment efficacy: Full </text>
   <text y="516.075" x="310.016,313.427,317.837,321.743,325.649,329.555,332.966,336.377,338.321,341.228,343.64,348.05,350.462,354.368,356.78,358.724,363.134,366.041,368.453,372.863,376.769,379.676,384.086,386.03,389.936,394.346,398.756,401.168,403.58,407.99,411.896,416.306,420.212,424.118,426.278,428.222,432.632,437.042,438.986,443.396,447.806,451.712,454.619,458.525,462.431,464.843,467.255,471.665,475.571,477.515,481.925,485.831,488.243,491.15,495.56,498.971,503.381,506.288,509.195,511.355,513.299,515.711,522.623,527.033,529.94,534.35,538.76,542.666" svgx:width="0.39,0.5,0.44,0.44,0.44,0.39,0.39,0.25,0.33,0.28,0.5,0.28,0.44,0.28,0.25,0.5,0.33,0.28,0.5,0.44,0.33,0.5,0.25,0.44,0.5,0.5,0.28,0.28,0.5,0.44,0.5,0.44,0.44,0.25,0.25,0.5,0.5,0.25,0.5,0.5,0.44,0.33,0.44,0.44,0.28,0.28,0.5,0.44,0.25,0.5,0.44,0.28,0.33,0.5,0.39,0.5,0.33,0.33,0.25,0.25,0.28,0.78,0.5,0.33,0.5,0.5,0.44,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">success (total urinary continence, no overactive detrusor), improve-</text>
   <text y="527.073" x="310.016,316.928,320.834,325.244,327.656,329.816,331.976,336.386,339.293,341.453,343.865,348.275,350.687,354.593,357.005,359.165,362.072,365.978,368.39,370.802,375.212,378.119,382.025,384.185,387.092,389.252,393.662,396.407,400.817,404.723,406.883,409.295,413.705,417.611,422.021,426.431,428.843,431.255,435.665,439.571,443.981,447.887,451.793,453.953,457.859,462.269,466.679,468.839,473.249,477.659,481.565,484.472,488.378,492.284,494.696,497.108,501.518,505.424,507.584,511.994,515.9,518.312,521.219,525.629,529.04,533.45,536.357,539.264" svgx:width="0.78,0.44,0.5,0.28,0.25,0.25,0.5,0.33,0.25,0.28,0.5,0.28,0.44,0.28,0.25,0.33,0.44,0.28,0.28,0.5,0.33,0.44,0.25,0.33,0.25,0.5,0.33,0.5,0.44,0.25,0.28,0.5,0.44,0.5,0.5,0.28,0.28,0.5,0.44,0.5,0.44,0.44,0.25,0.44,0.5,0.5,0.25,0.5,0.5,0.44,0.33,0.44,0.44,0.28,0.28,0.5,0.44,0.25,0.5,0.44,0.28,0.33,0.5,0.39,0.5,0.33,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">ment, or total failure ( urge incontinence and overactive detrusor).</text>
   <text y="538.071" x="310.016,316.379,320.24,323.606,328.475,330.842,333.704,337.07,339.932" svgx:width="0.72,0.44,0.39,0.56,0.28,0.33,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Results: </text>
   <text y="538.071" x="341.921,344.783,349.148,353.009,357.374,361.739,364.106,366.473,370.838,374.699,379.064,382.925,386.786,388.775,391.637,398.504,402.869,406.73,410.591,412.958,414.947,421.31,425.675,429.536,432.902,435.269,437.636,442.001,446.366,450.227,452.594,455.456,459.317,461.306,465.671,467.66,471.026,474.887,479.252,482.114,485.975,489.341,491.33,494.696,499.061,503.426,509.789,513.65,518.015,520.004,523.865,528.23,532.595,535.961,538.328,542.693" svgx:width="0.33,0.5,0.44,0.5,0.5,0.28,0.28,0.5,0.44,0.5,0.44,0.44,0.25,0.33,0.78,0.5,0.44,0.44,0.28,0.25,0.72,0.5,0.44,0.39,0.28,0.28,0.5,0.5,0.44,0.28,0.33,0.44,0.25,0.5,0.25,0.39,0.44,0.5,0.33,0.44,0.39,0.25,0.39,0.5,0.5,0.72,0.44,0.5,0.25,0.44,0.5,0.5,0.39,0.28,0.5,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Incontinence Impact Questionaire 7 scores showed consid-</text>
   <text y="549.069" x="310.016,313.877,316.739,320.6,324.965,327.332,331.193,333.83,336.197,343.064,347.429,350.291,354.656,359.021,362.882,369.749,373.61,377.975,380.342,382.979,387.344,391.709,394.346,400.709,404.57,408.431,412.796,416.162,418.799,422.66,425.522,427.889,431.75,434.612,437.249,439.616,442.478,446.339,450.2,452.567,459.434,463.295,467.66,470.027,472.142,474.779,479.144,483.509,490.871,493.508,497.872,500.734,503.371,507.736,511.597,513.964,516.331,520.193,524.557,526.924,530.291,532.928,537.293,541.154,545.654" svgx:width="0.44,0.33,0.44,0.5,0.28,0.44,0.25,0.28,0.78,0.5,0.33,0.5,0.5,0.44,0.78,0.44,0.5,0.28,0.25,0.5,0.5,0.25,0.72,0.44,0.44,0.5,0.39,0.25,0.44,0.33,0.28,0.44,0.33,0.25,0.28,0.33,0.44,0.44,0.28,0.78,0.44,0.5,0.28,0.25,0.25,0.5,0.5,0.83,0.25,0.5,0.33,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.5,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">erable improvement 12 weeks after treatment. 83% of patients had </text>
   <text y="560.067" x="310.016,313.877,316.244,318.611,322.976,325.343,329.204,333.065,335.432,338.06,340.427,347.294,351.659,354.521,358.886,363.251,367.112,373.979,377.84,382.205,384.572,387.2,391.565,394.427,397.055,399.917,404.282,406.649,409.016,411.644,415.01,419.375,423.236,427.097,430.958,434.324,437.69,440.318,444.683,447.545,450.173,452.54,456.905,460.766,463.394,465.761,468.623,472.484,476.345,478.712,485.579,489.44,493.805,496.172,498.799,505.163,507.53,509.897,514.262,516.89,520.751,523.379,526.241,530.102,534.467,538.832,542.693" svgx:width="0.44,0.28,0.28,0.5,0.28,0.44,0.44,0.28,0.25,0.28,0.78,0.5,0.33,0.5,0.5,0.44,0.78,0.44,0.5,0.28,0.25,0.5,0.33,0.25,0.33,0.5,0.28,0.28,0.25,0.39,0.5,0.44,0.44,0.44,0.39,0.39,0.25,0.5,0.33,0.25,0.28,0.5,0.44,0.25,0.28,0.33,0.44,0.44,0.28,0.78,0.44,0.5,0.28,0.25,0.72,0.28,0.28,0.5,0.25,0.44,0.25,0.33,0.44,0.5,0.5,0.44,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">clinical improvement or full success of the treatment with a reduc-</text>
   <text y="571.065" x="310.016,312.383,314.75,319.115,323.48,325.73,328.106,332.471,335.333,337.583,339.959,342.326,346.691,350.552,352.919,355.781,358.031,360.407,364.772,367.472,371.837,375.698,380.063,383.924,388.289,390.539,392.915,396.776,401.141,405.506,407.756,410.132,412.499,416.864,420.725,425.09,429.455,431.822,434.189,438.554,442.415,446.78,450.641,454.502,456.617,458.867,461.243,466.112,468.479,472.844,477.209,479.576,482.438,484.805,488.666,492.527,496.892,499.259,501.509,503.885,508.25,511.112,515.477,519.842,524.207,528.572,532.433,539.3,541.667,545.663" svgx:width="0.28,0.28,0.5,0.5,0.25,0.55,0.5,0.33,0.25,0.55,0.28,0.5,0.44,0.28,0.33,0.25,0.55,0.5,0.33,0.5,0.44,0.5,0.44,0.5,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.28,0.5,0.44,0.5,0.5,0.28,0.28,0.5,0.44,0.5,0.44,0.44,0.25,0.25,0.55,0.56,0.28,0.5,0.5,0.28,0.33,0.28,0.44,0.44,0.5,0.28,0.25,0.55,0.5,0.33,0.5,0.5,0.5,0.5,0.44,0.78,0.28,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">tion of their urgency and incontinence. Significant urodynamic </text>
   <text y="582.063" x="310.016,312.383,319.25,323.615,326.477,330.842,335.207,339.068,345.935,349.796,354.161,356.528,358.778,360.578,364.439,367.301,369.668,373.529,376.391,378.641,380.441,382.808,385.67,389.531,393.392,395.759,402.626,406.487,410.852,413.219,415.469,417.269,423.632,427.493,430.859,433.109,434.909,438.275,442.64,447.005,453.368,455.618,457.418,461.783,466.148,468.398,470.198,474.563,476.93,479.792,483.653,486.515,490.376,494.741,497.108,500.969,503.219,505.018,509.383,513.245,516.107,519.968,526.835,530.696,533.063,536.924,539.786,543.152,545.654" svgx:width="0.28,0.78,0.5,0.33,0.5,0.5,0.44,0.78,0.44,0.5,0.28,0.25,0.55,0.44,0.33,0.28,0.44,0.33,0.25,0.55,0.28,0.33,0.44,0.44,0.28,0.78,0.44,0.5,0.28,0.25,0.55,0.72,0.44,0.39,0.25,0.55,0.39,0.5,0.5,0.72,0.25,0.55,0.5,0.5,0.25,0.55,0.5,0.28,0.33,0.44,0.33,0.44,0.5,0.28,0.44,0.25,0.55,0.5,0.44,0.33,0.44,0.78,0.44,0.28,0.44,0.33,0.39,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">improvement after treatment was show on diferente parameters: </text>
   <text y="593.061" x="310.016,317.882,321.743,326.108,328.475,335.342,339.707,346.574,348.824,349.607,353.468,357.833,361.199,363.566,367.931,374.798,378.659,381.026,383.888,386.255,390.116,392.366,393.149,397.01,400.871,405.236,409.097,412.958,415.325,417.692,421.472,423.587,425.837,426.62,433.487,437.348,441.713,444.08,450.947,455.312,459.677,466.544,468.794,469.577,473.942,477.803,480.17,483.032,487.397,490.763,495.128,497.99,500.24,501.023,505.388,508.25,512.111,515.477,518.843,523.208,526.07,529.931,532.181,532.964,536.825,541.19,545.69" svgx:width="0.89,0.44,0.5,0.28,0.78,0.5,0.78,0.25,0.55,0.44,0.5,0.39,0.28,0.5,0.78,0.44,0.28,0.33,0.28,0.44,0.25,0.55,0.44,0.44,0.5,0.44,0.44,0.28,0.28,0.5,0.25,0.25,0.55,0.78,0.44,0.5,0.28,0.78,0.5,0.5,0.78,0.25,0.55,0.5,0.44,0.28,0.33,0.5,0.39,0.5,0.33,0.25,0.55,0.5,0.33,0.44,0.39,0.39,0.5,0.33,0.44,0.25,0.55,0.44,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Maximum cystometric capacity, maximunm detrusor pressure and </text>
   <text y="604.059" x="310.016,314.381,318.746,321.113,325.478,332.345,336.206,338.321,342.686,347.051,349.913,352.28,356.645,361.01,363.125,365.492,369.857,373.718,375.833,378.695,381.062,383.924,387.29,389.657,391.772,394.139,398.504,402.869,407.234,409.601,413.966,418.331,420.698,424.559,427.421,431.786,433.901,438.266,442.127,444.494,447.356,451.721,455.087,459.452,462.314,464.428,468.289,472.654,477.019,479.386,482.248,486.109,488.476,490.843,495.208,499.573,501.688,504.55,506.665,511.03,513.145,518.086,520.201,524.566,526.681,531.046,535.411,538.273" svgx:width="0.5,0.5,0.28,0.5,0.78,0.44,0.25,0.5,0.5,0.33,0.28,0.5,0.5,0.25,0.28,0.5,0.44,0.25,0.33,0.28,0.33,0.39,0.28,0.25,0.28,0.5,0.5,0.5,0.28,0.5,0.5,0.28,0.44,0.33,0.5,0.25,0.5,0.44,0.28,0.33,0.5,0.39,0.5,0.33,0.25,0.44,0.5,0.5,0.28,0.33,0.44,0.28,0.28,0.5,0.5,0.25,0.33,0.25,0.5,0.25,0.56,0.25,0.5,0.25,0.5,0.5,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">volume during the first involuntary detrusor contration ( p &lt; 0,05).</text>
   <text y="615.057" x="310.016,316.514,321.014,326.018,330.014,332.516,337.52,341.021,343.523,348.023,353.027,356.528,359.525" svgx:width="0.72,0.5,0.56,0.44,0.28,0.56,0.39,0.28,0.5,0.56,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Conclusions: </text>
   <text y="615.057" x="366.149,372.647,376.643,379.145,382.142,386.642,390.143,394.643,397.64,399.89,403.769,410.267,414.767,419.267,423.767,428.267,430.769,435.269,437.771,440.273,444.773,449.273,456.275,458.777,463.277,467.777,470.279,474.779,477.029,480.908,486.911,489.161,493.535,496.037,500.537,503.039,507.035,511.031,513.533,516.035,520.535,525.035,528.536,530.786,535.16,538.157,542.657,545.654" svgx:width="0.72,0.44,0.28,0.33,0.5,0.39,0.5,0.33,0.25,0.55,0.72,0.5,0.5,0.5,0.5,0.28,0.5,0.28,0.28,0.5,0.5,0.78,0.28,0.5,0.5,0.28,0.5,0.25,0.55,0.72,0.25,0.55,0.28,0.5,0.28,0.44,0.44,0.28,0.28,0.5,0.5,0.39,0.25,0.55,0.33,0.5,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Detrusor Abobotulinumtoxin A injections for </text>
   <text y="626.055" x="310.016,313.013,317.009,320.006,323.003,326.999,330.995,333.497,337.997,340.994,345.494,347.591,352.091,356.087,360.587,363.584,368.084,372.584,376.58,381.08,383.582,387.578,389.675,394.175,398.171,400.673,403.67,408.17,411.671,416.171,419.168,421.265,425.765,430.265,434.261,437.258,441.254,445.25,447.752,450.254,454.754,457.256,459.758,464.258,466.355,468.857,473.357,475.454,479.954,483.95,486.452,488.954,492.95,497.45,499.952,503.453,505.55,512.048,514.55,517.052,521.552,523.649,530.651,535.151,537.653,540.155,542.657" svgx:width="0.33,0.44,0.33,0.33,0.44,0.44,0.28,0.5,0.33,0.5,0.25,0.5,0.44,0.5,0.33,0.5,0.5,0.44,0.5,0.28,0.44,0.25,0.5,0.44,0.28,0.33,0.5,0.39,0.5,0.33,0.25,0.5,0.5,0.44,0.33,0.44,0.44,0.28,0.28,0.5,0.28,0.28,0.5,0.25,0.28,0.5,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.72,0.28,0.28,0.5,0.25,0.78,0.5,0.28,0.28,0.28,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">refractory neurogenic detrusor overactivity in patients with multi-</text>
   <text y="637.053" x="310.016,314.516,317.018,321.014,322.913,326.414,330.41,332.912,336.908,339.905,344.405,347.906,350.408,353.909,355.808,360.308,364.304,368.804,372.8,374.699,378.695,380.594,384.59,389.09,393.59,397.091,399.593,403.094,405.596,409.592,414.092,416.594,420.59,422.489,426.485,429.32,432.317,436.313,440.309,442.811,444.71,449.21,453.71,455.609,460.109,462.611,466.607,471.107,475.607,479.603,482.6,484.499,488.495,492.995,497.495,499.997,502.994,507.494,509.996,512.246,514.145,517.142,521.138,524.639,529.139,531.641,534.143,536.645,541.145,545.645" svgx:width="0.5,0.28,0.44,0.25,0.39,0.44,0.28,0.44,0.33,0.5,0.39,0.28,0.39,0.25,0.5,0.44,0.5,0.44,0.25,0.44,0.25,0.44,0.5,0.5,0.39,0.28,0.39,0.28,0.44,0.5,0.28,0.44,0.25,0.44,0.33,0.33,0.44,0.44,0.28,0.25,0.5,0.5,0.25,0.5,0.28,0.44,0.5,0.5,0.44,0.33,0.25,0.44,0.5,0.5,0.28,0.33,0.5,0.28,0.25,0.25,0.33,0.44,0.39,0.5,0.28,0.28,0.28,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">ple sclerosis have a consistente effect on bladder control, resulting </text>
   <text y="648.051" x="310.016,312.518,317.018,319.268,322.769,327.269,330.77,333.272,337.268,339.77,344.27,348.266,352.766,355.016,357.518,364.52,369.02,372.017,376.517,381.017,385.013,392.015,396.011,400.511,403.013,405.263,407.765,412.265,414.515,419.015,423.515,427.511,430.013,432.515,435.017,439.517,441.767,446.267,449.264,451.514,454.016,456.518,459.515,463.511" svgx:width="0.28,0.5,0.25,0.39,0.5,0.39,0.28,0.44,0.28,0.5,0.44,0.5,0.25,0.28,0.78,0.5,0.33,0.5,0.5,0.44,0.78,0.44,0.5,0.28,0.25,0.28,0.5,0.25,0.5,0.5,0.44,0.28,0.28,0.28,0.5,0.25,0.5,0.33,0.25,0.28,0.28,0.33,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">in sustained improvement in quality of life.</text>
   <text y="675.051" x="310.016,315.515,320.015,324.515" svgx:width="0.61,0.5,0.5,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">P945</text>
   <text y="686.049" x="310.016,313.517,318.521,322.517,325.019,330.023,334.019,339.023,343.019,347.015,349.265,353.765,356.762,359.012,364.016,368.516,373.52,378.02,382.52,387.02,392.024,396.524,401.528,404.03,407.531,415.028,417.278,421.778,426.782,431.786,434.036,437.033,441.533,444.53,447.032,451.532,456.536,460.532,462.782,465.284,470.288,472.538,480.035,484.535,487.037,491.033,493.283,500.78,505.784,508.286,511.283,513.785,518.789,521.291,525.287" svgx:width="0.39,0.56,0.44,0.28,0.56,0.44,0.56,0.44,0.44,0.25,0.5,0.33,0.25,0.56,0.5,0.56,0.5,0.5,0.5,0.56,0.5,0.56,0.28,0.39,0.83,0.25,0.5,0.56,0.56,0.25,0.33,0.5,0.33,0.28,0.5,0.56,0.44,0.25,0.28,0.56,0.25,0.83,0.5,0.28,0.44,0.25,0.83,0.56,0.28,0.33,0.28,0.56,0.28,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Incidence of hypogonadism and fatigue in male multiple </text>
   <text y="697.047" x="310.016,313.517,317.513,320.015,324.011,328.007,332.507,336.008,338.51,342.011,344.261,349.265,353.765,356.762,359.264,363.26,368.264,371.261" svgx:width="0.39,0.44,0.28,0.44,0.44,0.5,0.39,0.28,0.39,0.25,0.56,0.5,0.33,0.28,0.44,0.56,0.33,0.39" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">sclerosis patients</text>
   <text y="708.045" x="310.016,313.517,317.018,319.268,327.269,331.265,334.262,337.259,339.761,344.261,346.763" svgx:width="0.39,0.39,0.25,0.89,0.44,0.33,0.33,0.28,0.5,0.28,0.28" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">JJ Marriott</text>
   <text y="705.583" x="349.264" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="708.103" x="352.189,354.439,356.689,363.187,365.437,371.935,375.931,378.433" svgx:width="0.25,0.25,0.72,0.25,0.72,0.44,0.28,0.28" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, N Hall</text>
   <text y="705.583" x="380.935" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="708.103" x="383.86,386.11,388.36,394.858,397.108,403.111,407.107,409.609,414.109,418.105" svgx:width="0.25,0.25,0.72,0.25,0.67,0.44,0.28,0.5,0.44,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, N Reider</text>
   <text y="705.583" x="421.101" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="716.581" x="310.016" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:5.85px;stroke:none;">1</text>
   <text y="719.103" x="312.941,319.439,323.939,326.441,330.437,334.433,337.934,341.435,343.937,346.439,350.435,352.685,357.185,359.687,361.937,369.434,373.934,378.434,380.936,383.438,387.938,392.438,396.938,399.188,401.438,405.938,409.934,413.93,416.432,418.934,423.434,427.934,430.184,434.684,437.186,439.436,445.439,449.435,453.935,457.436,461.936,464.438,468.938,473.438,477.434,479.684,481.934,489.431,491.933,496.433,500.933,503.435,507.935,511.931,516.431,518.681,520.931,528.428,533.927,536.177" svgx:width="0.72,0.5,0.28,0.44,0.44,0.39,0.39,0.28,0.28,0.44,0.25,0.5,0.28,0.25,0.83,0.5,0.5,0.28,0.28,0.5,0.5,0.5,0.25,0.25,0.5,0.44,0.44,0.28,0.28,0.5,0.5,0.25,0.5,0.28,0.25,0.67,0.44,0.5,0.39,0.5,0.28,0.5,0.5,0.44,0.25,0.25,0.83,0.28,0.5,0.5,0.28,0.5,0.44,0.5,0.25,0.25,0.83,0.61,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">University of Manitoba, Section of Neurology, Winnipeg, MB, </text>
   <text y="730.101" x="310.016,316.019,320.519,325.019,329.519,334.019" svgx:width="0.67,0.5,0.5,0.5,0.5,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Canada</text>
  </g>
 </g>
</svg>
